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Abstract 
Biospectroscopy and its applications characterise in vitro and in vivo cells with abnormal 
proliferation capacities. Proliferation of endometrial tissues in regions other than the uterus 
lining is known as endometriosis. It affects around 10% of women in the UK and worldwide. 
This study tests Fourier-Transform Infrared Attenuated Total Reflectance (FTIR-ATR) and 
Raman Spectroscopy as a novel approach for early identification and in depth classification of 
Endometriosis. An implementation of a non-invasive and high-throughput screening method 
would eliminate bias and thus reduce screening costs. The potential for double screening 
endometriosis and cervical cancer simultaneously offers a cost effective approach. Each 
patient spectra can be added to the data base to create a thorough in-depth identification 
method for varying disease morphologies. Results showed that both spectral techniques 
successfully detected endometriosis presence when the right pre-processing methods were 
applied, although Raman spectroscopy carried a higher degree of sensitivity and was able to 
detect ovarian endometriosis alongside endometriosis. 
Thus far this study demonstrates that Benzoapyrene (B[a]P) is capable of inducing alterations 
in exposed Michigan Cancer Foundation-7 (MCF-7) cell populations even at very low doses of 
10-9M. B[a]P gradually reduces cell survival after 7 days exposure and induces long-term 
inhibition of cell growth. High dose exposure of 10-6M B[a]P causes short-term evasion of G1 
arrest and accumulation in S phase. These findings indicate that growth kinetics in vitro are 
important pre-determinants of MCF-7 cell susceptibility to genotoxic agents. Biospectroscopy 
and computational analysis produced biochemical signatures characterising dose and cell 
cycle related effects of B[a]P that indicated DNA alterations being induced. Overall the cell 
cycle is an important factor in genotoxic synthesis and cell proliferation. These findings can be 
linked to abnormal tumour growth in cancer. 
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1 Introduction 
Spectroscopy has long been a tool for physicists and chemists to obtain a reading of chemical 
and molecular properties held within samples. The method of obtaining a chemical fingerprint 
is non-invasive and has the ability to be applied to a very wide range of materials. It has even 
been applied to ancient art and archaeological findings to uncover underlying properties that 
have long since been lost (Sandak et al., 2010). The delicate and non-destructive nature of this 
technique makes it the perfect tool for in depth analysis of samples that are difficult to 
understand superficially and offers scientists the opportunity to reuse the samples for 
additional examination. Spectroscopy has also been applied on plant samples to characterise 
the cellular structures of wood (Tsuchikawa et al., 2015).  There has been a rapid shift towards 
the biological applications of spectroscopy (Carter et al. 2009). This field is referred to as 
biospectroscopy and there are many different types of spectroscopy techniques that can be 
used to obtain biological spectra. The most commonly used are currently infrared (IR) and 
vibrational spectroscopy using a light source in the form of IR light and a photon-emitting laser 
respectively. This study focuses on Fourier Transform Infrared Attenuated Total Resonance 
(FTIR-ATR) and Raman spectroscopy. The mechanisms of how these techniques work is 
explained in more detail in Section 1.1. Spectral measurements acquired through spectroscopy 
are used as characterisation tools on two tissue types originating from very different 
environments. One study analyses in vivo biological samples obtained from women suffering 
from endometriosis. The abnormal proliferation of endometrial tissue in ectopic regions is 
poorly understood. Examining patient samples through spectroscopy can bring new 
information to the medical field and can help to better characterise and diagnose the disease. 
The other study applies spectroscopy to cells grown in vitro. These are Michigan Cancer 
Foudation-7 (MCF-7) breast cancer cells that are being examined in conjunction with 
Benzo[a]pyrene (B[a]P). B[a]P is an environmental contaminant mainly found in tobacco 
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smoke, car exhaust fumes and industrial wastes (Guerreiro et al., 2016). Exposure to B[a]P 
during different times in the cell cycle have been shown to induce abnormal proliferation 
(Pang et al., 2012). Spectral analysis on these cells has the potential to uncover underlying 
mechanisms of genotoxicity and can help further understand the proliferative nature of 
tumours. 
1.1 Spectroscopy 
1.1.1 Spectroscopy as a Diagnostic Tool 
Spectroscopy has a biomedical application in its ability to distinguish between varying tissue 
types (Baker et al., 2014). It detects chemical bond vibrations that indicate structural 
alterations of cellular molecules (Theophilou et al., 2015). It has previously been used in 
identifying tissues in the cervix and in other neighbouring tissue (Chiriboga et al., 1998).  It can 
help detect signature biomarkers associated with a disease, which in turn can uncover 
underlying causation and aid treatment options (Gajjar et al., 2013). Endometriosis exhibits a 
wide variety of symptoms and phenotypes that do not directly correlate to the severity of the 
disease. Biospectroscopy has the potential to create a biochemical fingerprint of disease 
variations, (Chiriboga et al., 1998) offering the opportunity to build a new, more detailed 
disease characterisation method (Kraphy et al. 2009). In turn it can provide a non-invasive and 
more conclusive diagnostic method for women suffering from endometriosis.  
FTIR and Raman spectroscopy have been successfully used as diagnostic tools for the detection 
of cervical cancer and the papillomavirus in several studies (Taylor et al., 2011) (Harris et al., 
2009). Conventional Papanicolaou (Pap) smear screening has a sensitivity rate of 86.6% and 
specificity rate of 90.5%. FTIR has a sensitivity and specificity rate of 98.6% and 98.8% 
respectively. Furthermore when compared to the Pap smear, FTIR carries a better false-
negative rate (1.4% compared to 13.4%) and a negative predictive value (96.5% compared to 
72.3%) (Fung et al., 1997). This means that women suffering from endometriosis will be less 
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likely to receive a false-negative diagnosis and women receiving a clear diagnosis can be 
confident that they have been properly diagnosed. 
 Spectroscopy has a high throughput application that eliminates human bias and the need for 
manual interpretation of slides. A reduction in discarded slides and manual labour proves to 
be very cost effective. This could allow for a lower screening age to be implemented in the UK 
(Walsh et al., 2007). A preliminary study showed that FTIR spectroscopy was able to distinguish 
between eutopic endometrial tissue found in patients with and without endometriosis 
(Cheung et al., 2011). This shows promise for spectroscopy being used as a diagnostic and 
screening tool for endometriosis. Spectral analysis on cervical samples offer the potential of 
multiple disease screenings, as samples can be revisited and spectral data can be screened for 
endometrial cancer and endometriosis simultaneously. 
1.1.2 Using Spectroscopy for Characterisation 
Spectroscopy has the potential to detect molecular alterations and differences within samples 
to uncover their biological fingerprint. FTIR-ATR and Raman spectroscopy have been used to 
extract biological information from many different human sample types (Trevisan et al., 2012). 
Biospectroscopy has been successfully been used to distinguish between subtypes of human 
cancer, and can distinguish between subclasses of ovarian cancer (Theophilou et al., 2016). It 
has also been applied to corneal epithelial cells to identify putative stem cells, transit-
amplifying cells and terminally-differentiated cells (Fogarty et al.,(2013). Many types of cell 
populations can be characterised through IR biospectroscopy (Martin et al., 2010). 
Biospectroscopy is an incredibly sensitive tool that is even able to detect differences between 
base compositions of oligonucleotides (Kelly et al., 2009). It therefore has very strong 
characterisation abilities and is an essential tool in many biological investigations. 
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1.1.3 FTIR-ATR Spectroscopy 
FTIR spectroscopy works by shining a beam of infrared light onto a sample. Conventional IR 
spectroscopy can only shine one monochromatic beam at a time and takes measurements of 
several frequencies over a period of time (Butler et al., 2014). FTIR has the advantageous 
ability of exposing a sample to a multitude of frequencies simultaneously with one beam. This 
results in a high throughput method that acquires multiple wavelength readings over a large 
spectral range in a short amount of time. FTIR spectroscopy was coupled with an ATR 
attachment. This piece of equipment is fitted with a crystal that allows the FTIR machine to 
take measurements directly from solid or liquid samples. The crystal uses pressure to make 
direct contact with the sample. An IR beam passes through the ATR crystal at a 90° angle and 
is continuously reflects along the sample and the crystal in a process called total internal 
reflection. When the IR beam hits the sample an evanescent wave is formed which decays 
exponentially as it travels further into the sample. This process can be visualised in the 
schematic in Figure 1. 
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Figure 1 – A visual representation of FTIR spectroscopy with an ATR attachment containing a crystal. An 
infrared light source shines through a crystal where it continuously reflects between the sample and the 
diamond until it reaches a detector. An evanescent wave is formed where the IR light comes in contact with 
the sample and gets absorbed. Pressure is used to create contact between the crystal and the sample mounted 
onto a low-e slide 
Pressure is applied in order for the ATR crystal to make contact with the sample. This ensures 
that air does not get trapped between the sample and the crystal, as this would result in an 
inaccurate measurement as the evanescent wave gets distorted by the air (Sneppen et al,. 
2010). Light that reaches the samples through the evanescent wave is absorbed in different 
quantities depending on different molecular and cellular structures within the sample. The 
absorbance capacity is quantified into an absorbance spectrum containing individual wave 
numbers (also known as reciprocal centimetres, expressed in cm-1). Proteins and molecular 
structures within samples have been matched with specific wavelength numbers (Movasaghi 
et al., 2008). Since ATR relies on contact pressure, the sample could get damaged as it could 
get removed from the slide if it were to stick to the crystal, however, the damaged area would 
be minimal as it would be less than 2μm wide. 
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1.1.4 Raman Spectroscopy 
Another spectroscopy machine is the Raman photometer. This spectroscopy technique relies 
on a laser to beam photons onto the sample source. The laser is projected through a series of 
mirrors in order to reach the sample. Once they do so the photons are absorbed by the 
sample’s molecules and are subsequently reflected back; a process known as Raman scattering 
(Butler et al., 2016). During photon absorption, sample molecules get excited and vibrate at 
different rates depending on their chemical compositions. The absorbed photons experience 
a shift in their energy levels as some of the energy is retained in the excited sample. The 
reflected photon beam is directed by mirrors through a filter and a focusing lens or grating, 
before reaching a photometer. The described mechanism of Raman spectroscopy can be 
visualised in the schematic shown in Figure 2.  
 
Figure 2 – A visual representation of the mechanism employed during Raman spectroscopy. A laser beam is 
guided by mirrors to a sample mounted on a low-e slide. The laser is reflected off the sample and concentrated 
through a notch filter and focusing lens towards a spectrometer where sample data is detected and converted 
by software for analysis 
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Only around 1% of the laser emissions result in Raman scattering as the majority of the 
photons do not get absorbed but instead directly reflect off the sample in a process known as 
elastic or Raleigh scattering. Filters and grating techniques are often used to optimise the 
amount of pure Raman scattering being received and reflected. Surface enhanced Raman 
scattering has also been used to increase Raman scattering efficiency. This utilises 
nanoparticles embedded on top of the sample slides to capture background fluorescence and 
significantly reduces the signal to noise ratio. Raman scattering is detected in the form of 
Raman shifts that are converted into wavenumbers (cm-1) and allow us to obtain information 
about the underlying molecular structures of samples. Biological molecules such as nucleic 
acids, lipids and proteins can all be paired with specific wavenumber to create a biochemical 
fingerprint of the sample (Movasaghi et al in 2007). The laser used in Raman spectroscopy has 
the potential to burn through the sample and result in sample damage. The sample can’t be 
reused and the reading obtained with too high a laser power will be inaccurate as the sample 
morphology changes when it gets burnt. It is important to test the machine’s acquisition 
parameters on all new sample types to determine the appropriate custom setting. 
1.1.5 Sample Preparations 
In order to expose samples to spectral beams they need to be mounted onto low-e slides. 
These resemble conventional glass microscope slides but are coated with Ag/SnO2. The slides 
provide a fantastic tool for carrying the samples without contributing any chemical signals to 
the readings. They are almost entirely transparent to visible light (from 4000cm-1 to 400 cm-1) 
and therefore do not produce any interfering absorptions. Whilst low-e slides do not obscure 
sample readings, they carry the capacity of reflecting mid infrared radiation efficiently 
(Severcan & Haris, 2012). This makes them crucial components in FTIR-ATR spectroscopy. 
Samples are regularly fixed directly onto the slides in fixative mediums such as Thin Prep, 
ethanol (EtOH) or paraformaldehyde. 
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1.2 Endometriosis 
1.2.1 Sample Origin and Study Participants 
Biospectroscopy was applied to patient samples to test its application as a diagnostic tool for 
detecting endometriosis. The women participating in the study were being treated for pelvic 
pain or sub fertility induced by endometriosis. A total of 43 patient samples were collected 
from women aged 16 to 67 years suffering from various degrees of endometriosis. Disease 
stages ranged from 1-4 (according to the American Society for Reproductive Medicine’s 
grading system shown in Figure 3) and showed a manifestation of both red and black lesions. 
Ovarian endometriosis was present in 7 patients; all of whom were in stage ≥ 3. This was an 
anonymous blind study that included 11 endometriosis free patients as negative controls. 
Spectral data obtained from endometriosis samples was divided into subclasses for in depth 
analysis, with the aim to uncover biochemical trends associated with different aspects of the 
disease.  
These subclasses are as follows: 
 Endometriosis presence (no endometriosis vs. endometriosis-free control) 
 Disease stage (1-4) 
 Disease morphology (red or black lesions) 
 Ovarian endometriosis presence 
Cervical cytology samples were obtained through the use of a Tao Brush on the cervix. The 
collected cell material was stored at 37°C in thin prep solution. Full consent forms were 
completed and samples were obtained with local Institutional Review Board (IRB) approval 
from the Gold Coast, Australia. 
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1.2.2 Endometriosis Pathology 
Endometriosis is defined as the occurrence of endometrial-like tissue, specifically glands and 
stroma, growing outside the uterus. Whilst the tissue greatly resembles endometrium, it 
remains histologically different. Its presence causes chronic inflammation, scar tissue, 
adhesions and lesions that grow and bleed in response to hormonal changes. Endometriosis 
is usually located within the pelvic region and has been found in all the pelvic organs such as 
the bladder, uterus, ovaries, fallopian tubes, bowel and peritoneum. It can also present itself 
outside the pelvic cavity and has been documented in women post hysterectomy and in 
extreme cases has been discovered behind the knee and in the brain (Machairiotis et al., 
2013). 
1.2.3 Causation 
Whilst the true cause of endometriosis still remains unclear, several proposed theories exist. 
Sampson was the first to name and outline the pathogenesis of endometriosis (Sampson, 
1927). The first proposed cause of endometriosis examined the theory of retrograde 
menstruation (Speert, 1958). The retrograde flow of menstrual content through the fallopian 
tubes causes the dissemination of endometrial tissue to the peritoneum and ovaries. Since 
retrograde flow is a common occurrence in most menstruations and endometrial cells are not 
histologically identical to endometriosis lesions, this theory has since been disputed (Brosens 
& Benagiano, 2011). 
Currently the most widely acknowledged theory focuses on oestrogen dominance, where the 
level of progesterone is greatly outweighed by oestrogen. This correlates to the treatment for 
relieving endometriosis symptoms through the reduction of oestrogen production 
(Leyendecker at al., 1998). 
It has also been suggested that Metaplasia is in some way related. This is the process where 
cells have the ability to change into tissue types that are different to their original state. Adult 
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endometrial cells could have retained the ability to transform into reproductive tissue; a trait 
that was in place in the embryonic stage during uterus development (Latham Macer & Taylor, 
2012.) 
Endometriosis may be an inherited disease. First-degree relatives of women suffering from 
endometriosis have a higher chance of being diagnosed with the disease. The suspected 
genetic pre-disposition has been attributed to a loci near chromosome 7p13-15 (Zondervan et 
al., 2007). 
The dispersal of endometrial fragments through lymphatic or vascular pathways could allow 
endometrial tissue to establish itself around the body (Sourial, Tempest & Hapangama, 2014). 
This accounts for the presence of endometriosis outside the pelvic cavity, such as the eyes, 
brain and lungs. 
1.2.4 Symptoms and Treatment 
The American Society for Reproductive Medicine has established a classification chart to help 
quantify the progression of endometriosis (Figure 3). It is based on the presence and severity 
of endometriomas or adhesions, the extent and depth of the disease, as well as its location. 
Through a numerical scoring system, based on physical pathogenesis, endometriosis can be 
categorised into Stage 1 (minimal), Stage 2 (mild), Stage 3 (moderate) and Stage 4 (severe). 
Black lesions, ovarian endometriosis and infertility are associated with the later more severe 
stages (American Society for Reproductive Medicine, 1997). 
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Figure 3 – A visual guide to classify endometriosis stage following a numerical scoring system, by the American 
Society for Reproductive Medicine, 1997 
There is currently no conclusive cure for endometriosis but there are several options aimed at 
managing and reducing its symptoms. Removal of endometriosis through laproscopic excision 
or ablation can be successful, although the latter works best on red lesions found in the earlier 
stages. Triggering a temporary medical menopause through the administration of hormonal 
medication can help to shrink lesions over time (Muñoz-Hernando et al., 2015). Contraceptives 
containing gonadotropin-releasing hormone (GnRH) analogues or progestins are widely used. 
These can be released through intra uterine devices, injections, tablets or nasal sprays. 
Even though the endometriosis tissue is benign, it causes great discomfort and is accompanied 
by symptoms of pelvic pain, dysmenorrhea, and dyspareunia. 10% of the female population 
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has been diagnosed with endometriosis (Gruppo italiano per lo studio dell'endometriosi, 
1994). 20–25% of these patients are asymptomatic and many women’s symptoms are 
misdiagnosed (Bérubé, Marcoux & Maheux, 1998).  Disease prevalence is therefore likely to 
be greater than 10%. 
The probability of a successful diagnosis increases with age, as the symptoms grow more 
severe. If the presence of endometriosis is suspected, it can only be confirmed through 
laparoscopic surgery. This is currently the only conclusive diagnostic method for the disease. 
1.2.5 Current Diagnostic Methods 
Unlike endometrial cancer, there are currently no active screening methods for the detection 
of endometriosis. MRI scans, ultrasounds, and gynaecological examinations can be suggestive 
of the disease but will not detect smaller lesions. Elevated CA-125 serum levels can be an 
indicator of endometriosis, however this method of diagnosis only has a sensitivity of 61.1% 
and a specificity of 87.5% (Chen et al., 1998). 
Diagnosing endometriosis by laparoscopic surgery involves a keyhole surgery through the 
abdomen to examine the affected region with a light-bearing microscope. Surgery is very 
invasive and carries the risk of complications and side effects (Kennedy et al., 2005). Spectral 
analysis on LBC samples avoids the need for surgery as a diagnostic tool and offers a non-
invasive and safe screening method that would allow women to detect endometriosis at early 
stages when the disease is easier to maintain. 
1.2.6 Liquid Based Cytology 
Endometrial samples are collected through several devices made up of varying materials and 
shapes. These include Novak’s curette, Vabra, Pipelle, Masterson’s curette, Accurette, 
Endorette, Gynoscann, Leicester, endometrial needle, Cornier Pipelle, Explora and the Tao 
Brush. The majority of these have a diagnostic accuracy for detecting endometrial cancer of 
80% (Rullo et al., 2015). 
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There is however a vast difference in patient discomfort associated with these different 
collection methods. The Pipelle is the most commonly used sampling method and involves the 
collection of a biopsy. This process can be very painful and is concentrated on one location. 
Therefore small localised spots of cancer or endometriosis are likely to be excluded from the 
sample. The Tao Brush is gaining increased popularity in replacing the conventional smear test 
for cervical cancer screening (Zhu et al., 2007). 
The Tao Brush is protected from vaginal and endocervival contamination through a protective 
sheath and it covers a wide collection area. This results in a sensitivity rate of 95.5%, and up 
to 100% specificity when detecting endometrial carcinoma (Del Priore et al., 2001). The 
method of preparing and processing cervical samples in suspension is known as liquid based 
cytology (LBC). This offers a clearer representation of the samples as it prevents blood and 
mucus from concealing disease presence during microscopic examination (Williams et al., 
2008). The cost effectiveness, increased sensitivity, and the option to re-use samples are 
encouraging a switch to LBC (Cox, 2004). This movement allows for biospectrocopy techniques 
to be applied more readily in the medical field. It offers the potential to provide doctors with 
a multiple screening tool that is non-invasive and carries a higher accuracy of diagnosis. 
1.3 MCF-7 Cells 
1.3.1 Study Overview 
MCF-7 cells were treated with a range of B[a]P concentrations to understand its genotoxic 
synthesis and to uncover the mechanisms behind B[a]P induced G0/G1 arrest evasion. MCF-7 
cells have previously shown an evasion of G0/G1 arrest following a B[a]P treatment (Davis et 
al,. 2002). 
MCF-7 cells grown in culture were screened for protein expression of Cytochrome P450 (CYP) 
isoforms; CYP1A1 and CYP1B1. These are genes encoding for catalytic enzymes involved in the 
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conversion of pro-carcinogens into carcinogens, or genotoxins. They have been found to be 
present at elevated levels in many cancer patients. Previous studies have shown that the cell 
cycle plays in the homeostasis of proliferating tissues (Davidson et al., 2012) and the 
susceptibility of B[a]P (Hamouchene et al., 2011).  
Cells were grown and arrested in different phases of the cell cycle to identify how G1 arrest 
and quiescence can be evaded, whilst demonstrating how expression of CYP is altered at 
different stages of the cell cycle. The cell cycle concentration will follow the method close to 
the one used by Jiao et al., (2007), where flow cytometry was performed in order to confirm 
that the cells are distributed in the correct phases.  Biospectroscopy was applied to determine 
whether there are apparent spectral differences between different culture and treatment 
methods of MCF-7 cells, and whether these differences can be categorised with a specific 
biochemical fingerprint. 
1.3.2 Benzo[a]pyrene 
Benzo[a]pyrene (B[a]P) is an environmental contaminant mainly found in tobacco smoke, car 
exhaust fumes and industrial wastes (Guerreiro et al., 2016). It has pro-mutagenic and pro-
carcinogenic properties and damages DNA through the formation of DNA adducts (Genies et 
al., 2016). It has been found to be non-toxic until it enters the plasma membrane and binds to 
the Aryl hydrocarbon receptor (AhR). Once bound, it activates AhR causing it to translocate 
into the nucleus where it dissociates (Figure 4). Active AhR is responsible for the regulation of 
transcriptional responses and therefore involved in controlling the expression of many genes 
(Bersten et al., 2013). 
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Figure 4 – A representation of B[a]P uptake at the cell membrane. Binding of B[a]P activates the AhR receptor 
allowing for xenobiotic metabolism of genes. (Figure obtained from Bersten et al., 2013) 
1.3.3 Cytochrome P450s 
This particular research project will focus on the expression of CYP isoforms CYP1A1 and 
CYP1B1. These enzymes belong to a large superfamily containing over 11500 protein 
variations; they have catalytic activity and mediate oxidation of organic substances. The 
number following CYP refers to the gene family (CYP1) whilst the adjacent capital letter refers 
to the subfamily (CYP1A/ CYP1B). The final number indicates which specific gene is being 
referred to (CYP1A1). Italics are used when discussing the gene with regards to the enzyme it 
encodes for; CYP1A1 gene encoding CYP1A1 enzyme. The Human Genome Project identified 
57 individual genes coding for CYP enzymes (2004). In humans CYPs are often found in the 
cell’s endoplasmic reticulum or by the inner membrane of mitochondria (Berka et al. 2011). 
Past research has indicated that CYP isoforms are involved in cancer formation and treatment. 
This concerns prostate, breast, ovarian, kidney and many other forms of cancer (Rodriguez-
Antona, 2006). This is due to CYP’s metabolic activity of exogenous and endogenous 
substrates, often aiding the oxidative conversion of pro-carcinogens into genotoxic 
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metabolites (Jiao H, 2007). It appears that a variation of CYP expression influences the 
susceptibility that the target cells have towards pro-carcinogens. Gajjar et al (2012) performed 
a meta-analysis to determine whether there was indeed a link between the up-regulation of 
CYP polymorphisms and an increased risk of ovarian cancer. It focused on hormone-induced 
carcinogenesis since CYP1B1 catalytic activity (converting non-toxic E2 into 4OH2 E2 which has 
active genotoxic activity) is affected by the levels of oestrogen present. The meta-analysis 
showed a weak trend where homozygous Leu432Val (CYP1B1 Polymorphism) expression 
brought reduced risk, but not enough significance was found overall and the study remained 
inconclusive. 
1.3.4 MCF-7 Cell Morphology 
The types of cells that will be cultured in this research project are MCF-7 cells. They are an 
immortal breast adenocarcinoma cell line originating from Detroit and established by Soule et 
al., in 1973. They are ideal for research use because of their resilience, and they are also easy 
to grow and hard to kill. They also incorporate oestrogen receptors in their cell cytoplasm and 
can process oestrogen in the form of oestradiol (Lykkesfeldt & Briand, 1986). Oestrogen 
receptors are known to interact with the AhR during gene regulation (Matthews & Gustafsson, 
2006). Since B[a]P is an exogenous ligand for the AhR, using an oestrogen receptor positive 
cell line to study B[a]P genotoxicity is crucial. 
MCF-7 cells grow in a monolayer and exhibit strong cell-cell adhesion. Their morphological 
phenotype has been described as resembling cobblestones (Lombardo et al 2014).  Figures 5 
and 6 show cells grown for 24 hours and 96 hours respectively. For imaging purposes 1 x 105 
cells were grown directly on low-e slides submerged in a 60 x 15mm petri dish filled with 
media. 
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Figure 5 – S phase concentrated cells grown for 24 hours imaged on a low-e slide. The scale bar shows 50μm 
and 20μm 
 
Figure 6 – G0/G1 concentrated cells grown for 96 hours imaged on a low-e slide. The scale bar shows 50μm and 
20μm 
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1.3.5 Importance of Cell Cycle Stage in Experimental Studies 
This research project aims to observe the molecular delineation of CYP isoforms (CYP1A1 and 
CYP1B1) by administering B[a]P at different concentrations in conjunction with the 
manipulation of the cell cycle. In the cell cycle the G1 phase is where cell growth occurs whilst 
the S phase controls replication and DNA synthesis. Cells have to pass the restriction point, 
between G1 and S phase, in order to undergo replication and later division. If the restriction 
point is not passed then cells remain in G1 arrest, or quiescence, and are unable to pass into 
the subsequent phases. An illustration of the cell cycle can be seen in Figure 7. 
 
Figure 7 – An illustration showing the progression of cell cycle phases starting at G1 
Failure to regulate the cell cycle restriction point accordingly results in the avoidance of arrest 
by cells (Foster et al., 2011). This characteristic has been linked to the uncontrolled growth of 
tumours, as the cells are able to continuously re-enter the cell cycle (Zölzer, Mußfeldt & 
Streffer, 2014). The choice to manipulate the cell cycle in this research project relates to a 
previous studies conducted by Jiao in 2007, which also incorporated CYP1A1 expression. He 
indicated that tissue turnover is a potential important factor influencing the susceptibility of 
target cells to genotoxins. Jiao (2007) hypothesised that avoidance of G1 phase arrest 
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influences transforming activity of genotoxins (DNA-adduct forming carcinogens). His findings 
showed that the majority of cells exposed to non genotoxins would avoid G1 arrest and 
accumulate in S phase. After exposure genotoxic B[a]P induced the up-regulation of CYP1A1 
expression, this effect was significantly highest in S phase concentrated cells. This shows that 
the CYP expressing cells are able to avoid quiescence and become highly replicated in S phase. 
The consequences of this are that an increased cell population is grown which expresses a CYP 
gene which will go on to catalyse pro-carcinogens and cause DNA damage. These experiments 
show that the growth kinetics of cells play an important role in the expression of CYPs. Being 
able to observe the effect that different expression levels of CYP isoforms have, in conjunction 
with their place in the cell cycle, gives insight to the way in which genotoxic synthesis is driven 
and in what ways quiescence is avoided. 
Another important regulator of the cell cycle is p21 (WAF1/CIP). This is a p53-dependent gene 
and is strongly involved in controlling the cell cycle arrest in G1 phase (Overton et al., 2014). A 
relationship has been observed between p21 and bcl-2, where p21 suppression can be induced 
when bcl-2 is over expressed (Dai et al., 2016). This results in an evasion of arrest and bcl-2 
over expression also inhibits apoptosis. It is not surprising that bcl-2 is often found at elevated 
levels in tumours, as these cells have overridden the natural cell cycle defence mechanisms to 
halt cell proliferation. 
1.4 Aims and Objectives of Current Study 
Overall this research project aims to bring new insights into ways in which spectral techniques 
can be applied. Other aims and objectives of this study are as follows: 
 Use FTIR-ATR and Raman spectroscopy as a novel tool to screen patients for 
endometriosis. 
 Provide a non-invasive procedure that could increase the detection rate and eliminate 
surgeon bias during surgical diagnosis. 
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 Reduce the number of undiagnosed women due to the varied symptoms associated 
with the disease. 
 Identify the different spectral regions to lead the way in uncovering the aetiology of 
the disease. 
 Gain a better understanding of the mechanism of avoiding quiescence to get the closer 
to the goal of providing new cancer treatments and cures. 
 Demonstrate that B[a]P synthesis is cell cycle dependant. 
 Outline the proliferative function of CYP isoforms during B[a]P genotoxic synthesis. 
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2 Materials and Methods 
2.1 Biospectroscopy Sample Preparation 
In order to apply spectroscopy techniques to samples, the samples need to be fixed and 
suspended onto reflective low-e slides. The LBC samples were collected and stored in Thinprep 
fixative, eliminating the need for a fixation step. 5ml of the LBC samples were vortexed then 
centrifuged at 1500rpm for 5 minutes. The supernatant was aspirated and the pellets 
underwent 3 washes using 3ml of autoclaved double distilled water and were spun at 1500rpm 
for 5 minutes. After aspirating the supernatant the pellet was re-suspended in 1ml of 
autoclaved double distilled water and pipetted onto previously cut low-e slides (1cm by 1cm). 
These were left to dry overnight and were then stored in a desiccator awaiting analysis (Figure 
8). 
 
Figure 8 – Photograph showing EtOH fixed MCF-7 samples air-drying on the bench after being suspended onto 
1cm by 1cm low-e slides 
For MCF-7 spectral analysis 1 x 105 cells were grown in triplicate T25 flasks (25cm2 surface 
area) and concentrated in S phase (24h) or G0/G1 phase (96h) before being treated with 25μl 
of B[a]P at concentrations of 10-9M, 10-6M and 0M (Dimethyl Sulfoxide (DMSO) control) for 24 
hours. Media was refreshed 5 hours before treatment in G0/G1 phase concentrated flasks. 
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Trypsin was added to the flasks to lift the cells for collection. The collected cells were washed 
three times with 5ml 70% EtOH centrifuged at 1500rpm for 5 minutes. The cells were left to 
fix in EtOH at room temperature for one hour. After fixing cells were again centrifuged and re-
suspended in 1ml of EtOH, this was gently pipetted onto low-e slides, left to dry overnight and 
subsequently stored in a desiccator. 
2.2 FTIR-ATR Spectral Acquisition 
Sample readings were obtained using a Bruker Vector 27 FTIR spectrometer with a Helios ATR 
attachment containing a diamond crystal (Bruker Optics Ltd., Coventry, UK). 10 measurements 
were taken from independent points across the sample. The ATR crystal was cleaned using 
distilled water before every measurement to ensure no cross contamination occurred 
between sample points. A background spectrum was taken between every sample to account 
for environmental variations. Bruker OPUS software was used to convert spectra into 
absorbance values. 
2.3 Raman Spectral Acquisition 
Measurements were taken using an InVia Renishaw Raman spectrometer (Renishaw plc, 
Gloucestershire, UK) within the 400cm-1 to 2000cm-1 wavelength region. A total of 1075 
spectral measurements were obtained from the endometriosis samples. 25 random points 
were mapped on each of the 43 sample slides. Measurements were obtained using 10% laser 
power with a 13 second exposure period and three repeat acquisitions. Epithelial like samples 
have a tendency to be more delicate, so low laser power was used to avoid burning through 
the sample material to ensure the slide could be revisited. A total of 504 spectral 
measurements were obtained from the MCF-7 sample slides. 28 random points were mapped 
across each slide. Measurements were taken using 100% laser power with a 15 second 
exposure and three repeat accumulations. All of the spectra were individually examined for 
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cosmic rays. These present themselves as spurious sharp peaks and were excluded from the 
spectra using Renishaw's WiRE (Windows-based Raman Environment) software. 
2.4 Pre-Processing Spectra 
Data obtained through Raman and FTIR-ATR spectroscopy was analysed using Matlab 
(Mathworks, Natick, MA, USA) coupled with the IRootlab toolbox specifically designed for 
biospectroscopy data analysis (Trevisan et al., 2013). 
It is of great importance to apply pre-processing methods and to Spectra were cut to focus on 
the wavelengths falling between 1800cm-1 and 900cm-1 for FTIR-ATR (Figure 9) and between 
2000cm-1 and 400cm-1 for Raman (Figure 10). This is the region associated with the biological 
spectral fingerprints. 
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Figure 9 – FTIR-ATR raw spectral data from LBC samples of endometriosis and endometriosis free patients (control). All curves contained in the raw data set are shown as Absorbance (a.u) 
peaks over Wavenumber cm-1. A) FTIR-ATR raw uncut spectra ranging from 4000 cm-1 and 500 cm-1. B) FTIR-ATR spectra cut between 1800cm-1 and 900cm-1 
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Figure 10 – Raman raw spectral data from LBC samples of endometriosis and endometriosis free patients (control). All curves contained in the data set are shown as Absorbance (a.u) 
peaks over Wavenumber cm-1. A) All raw uncut Raman spectra ranging from 2000 cm-1 to 300cm-1. B) Raman spectra cut to 2000cm-1 to 400cm-1 
In Vitro and in Vivo Biospectroscopy Applications 
 
41 | P a g e  
 
In order to compress and smooth out the data sets the following algorithms were applied first: 
rubber band, Savitzky-Golay (SG) differentiation (for FTIR-ATR), and polynomial (for Raman). 
Spectra were then normalised by alignment to the amide I peak at 1650 cm−1, or through 
vector normalisation. Finally, background noise and scatter was removed through trained 
mean centring (for FTIR-ATR) and a de-noising function (for Raman). 
The FTIR-ATR and Raman spectra were each subjected to three different combinations of pre-
processing methods. These included the following: 
 Rubber band-Amide I (for both FTIR-ATR and Raman) 
 Rubber band-Vector normalisation (for both FTIR-ATR and Raman) 
 SG differentiation-Vector normalisation (for FTIR-ATR only) 
 Polynomial-Vector normalisation (for Raman only) 
In Figures 11 and 12 (endometriosis spectra) and Figures 13 and 14 (MCF-7 spectra) these pre-
processing methods can be visualised as a guide to understand how the pre-processing 
algorithms mould and align the spectral acquisitions. 
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Figure 11 – FTIR-ATR raw data from LBC samples of endometriosis and endometriosis free patients underwent several pre-processing steps in order to facilitate analysis. A combination of 
algorithms were applied including: A) Rubber band. B) Rubber band-Amide I. C) Rubber band-Amide I-Trained mean centering. D) Rubber band-Vector normalisation. E) Rubber band-
Vector normalisation-Trained mean centering. F) SG differentiation. G) SG differentiation-Vector normalisation. H) SG differentiation-Vector normalisation-Trained mean centering
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Figure 12 – Raman raw data obtained from LBC samples of endometriosis and endometriosis free patients (control) underwent several pre-processing steps in order to facilitate analysis. A 
combination of algorithms were applied including: A) Rubber band. B) Rubber band-Amide I. C) Rubber band-Amide I-Denoise. D) Rubber band-Vector normalisation. E) Rubber band-
Vector normalisation-Denoise. F) Polynomial G) Polynomial-Vector normalisation. H) Polynomial-Vector normalisation-Denoise
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Figure 13 – FTIR-ATR raw data, obtained from MCF-7 cells exposed to B[a]P concentrations of DMSO control, B[a]P 10-9M and 10-6M, underwent several pre-processing steps in order to 
facilitate analysis. A) All raw FTIR-ATR spectra ranging from 4000 cm-1 and 500 cm-1. B) FTIR-ATR spectra cut between 1800cm-1 and 900cm-1. A combination of algorithms were applied 
including: C) Rubber band. D) Rubber band-Amide I. E) Rubber band-Vector normalisation-Trained mean centerting. F) SG differentiation-Vector normalisation-Trained mean centering
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Figure 14 – Raman raw data, obtained from MCF-7 cells exposed to B[a]P concentrations of DMSO control, B[a]P 10-9M and 10-6M, underwent several pre-processing steps in order to 
facilitate analysis. A) All raw Raman spectra ranging from 4000 cm-1 and 500 cm-1. B) Raman spectra cut between 1800cm-1 and 900cm-1. A combination of algorithms were applied 
including: C) Rubber band. D) Rubber band-Amide I. E) Rubber band-Vector normalisation-Trained mean centerting. F) SG differentiation-Vector normalisation-Trained mean centering
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2.5 Spectral Analysis 
Pre-processed spectral data can be sorted and classified by applying a combination of both 
supervised and unsupervised algorithms. Supervised algorithms classify data sets according to 
predefined predictions based on a known data set. The supervised algorithm that was used 
was linear discriminant analysis (LDA). Unsupervised algorithms cluster data without previous 
information on the data; it based purely on the patterns that are recognized within the data 
set. (Trevisan et al., 2012). The unsupervised algorithm used was principal component analysis 
(PCA). Principal components were given a ranking score representing variance. This allowed 
for data point clusters and segregation to be illustrated. Principal components were chosen to 
capture > 95% variance held within the data set.  
Large variables can be sorted when applying a combination of supervised and unsupervised 
algorithms. PCA minimises the variance within classes, to account for heterogeneity of similar 
tissue samples. Meanwhile LDA maximises the variance between classes, allowing for 
diagnostic differences to be noticed. Mapping PCA alongside LDA (PCA-LDA) increases the 
distribution of variance throughout the data set.  
Processed data can be visualized in 1, 2 and 3 dimensional PCA-LDA scatter plots. The graphs 
show data over LD1, LD2 and LD3. This represents the PCA-LDA principal component rankings 
where LD1 is ranked 1st and captures > 90% of variance, LD2 is ranked 2nd then LD3 is ranked 
3rd capturing the remaining variance. 
The 1 dimensional graphs include a linear representation of LD1 and a linear representation 
of LD2. The scores plots contain a data trend line that illustrates data variance distribution. 
The 2 dimensional graphs show LD1 mapped alongside LD2. The 3 dimensional graph maps 
LD1, LD2 and LD3 together. Ellipse walls containing 95% of the data points were drawn on the 
2D and 3D scatterplots to help illustrate data trends. Cluster vector loading plots illustrate the 
mean difference between subclasses. The differences are shown as peaks, where the height 
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of the peak relates to the increased dissimilarity between disease/treatment classes and the 
control (coefficient 0). The 8 largest peaks are labelled with their corresponding wavelengths. 
The scatter plots and cluster vectors graphs are shown in Section 3. 
2.6 Statistical Analysis 
In order to determine whether results carried statistical significance several statistical 
methods were applied to the data. After undergoing principal component linear discrimination 
analysis (PCA-LDA), LD1 values (which captures > 90% of variance) were tested for significance. 
P values were calculated using one-way analysis of variance to test if data means were 
significantly different.  
Bartlett's test for equal variances analysed the significance of variance in the data. Anova tests 
included Dunnett’s multiple comparison test and Tukey’s multiple comparison test. The 
former analyses the significant difference between the controls and disease/treatment 
classes, and the latter compares each individual class to the other. An unpaired two tailed t-
test and an f-test to compare variances were used for analysis of endometriosis-free control 
vs. no endometriosis. R2 values were obtained through linear regression analysis to help 
predict the linear relationship between the data classes. All tests were performed with a 
confidence interval of 95% difference when P < 0.05. Error bars illustrating standard deviation 
values were added to the bar graphs and line graphs. These were calculated to measure 
significance of variance between treatment conditions. 
2.7 Chemicals and Cell Culture Media  
The chemicals used in this study, including B[a]P and DMSO, were obtained from Sigma 
Chemical Co. (Poole, Dorset, UK).  25µl of DMSO stock solution was used per 5ml of culture 
media. All consumables were obtained from Invitrogen Life Technologies (Paisley, UK).  
In Vitro and in Vivo Biospectroscopy Applications 
 
48 | P a g e  
 
MCF-7 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM). The media was 
supplemented with 10% heat inactivated foetal bovine serum (FBS) and 1% 
penicillin/streptomycin (penstrep). Routine culture of MCF-7 cells was carried out in T75 flasks 
(75cm2 surface area), and they were incubated at 37°C in a humidified atmosphere containing 
5% CO2 in air. Every 7 days cells were passaged for maintenance using Trypsin (0.05%)/EDTA 
(0.02%). This is heat activated in a 37°C incubator (Figure 15) for 5 minutes to disaggregate 
adherent cells. Culture media and trypsin were pre-warmed in a water bath turned to 37°C for 
20 minutes (Figure 16). Cell culture was performed in a class II laminar flow hood (Figure 17) 
which was run for 20 minutes and cleaned thoroughly with 70% EtOH before every use. 
 
Figure 15 – Photograph showing T25 experimental flasks containing 2.5ml of trypsin being activated in a 37°C 
incubator 
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Figure 16 – Photograph showing media and trypsin being warmed in a water bath at 37°C 
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2.8 Clonogenic Assay 
A clonogenic assay was performed to study the dose response of B[a]P on cell survival. B[a]P 
was diluted in DMSO to obtain concentrations of 1.0μM, 0.1μM, 0.01μM and 0.001μM. To 
account for DMSO presence in the dilutions, a treatment of DMSO only was used as a vehicle 
control. MCF-7 cells were split and then counted using a haemocytometer. 500 cells were 
seeded in in T25 flasks containing 5ml of DMEM complete media. Triplicate flasks were seeded 
for each of the five treatments (four B[a]P concentrations, one control). 25μl of treatment 
dose was then added to the cells on the day of seeding. The cells were incubated for 24 hours, 
after which media was replaced with fresh DMEM. Seven days post seeding, cells were fixed 
and stained for counting. Media was aspirated and cells were fixed for 30 minutes with 5ml of 
70% EtOH. EtOH was aspirated and 2ml of 5% Giemsa was added to the base of the T25 flasks. 
The cells were left to stain for 20 minutes with occasional shaking to distribute the Giemsa 
evenly. Cell colonies were counted using a light box. The clonogenic assay was performed in 
triplicate and repeated three independent times. 
Cell colony count was determined through visual observation and interpretation. Only the 
large colonies were counted. The same critical assessment was used throughout the counts. A 
visualisation of the counted colonies vs. stained cells that were not counted is shown in Figure 
18. 
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Figure 18 – Photograph showing the flasks obtained from clonogenic assay. Counted colonies were circled in 
blue 
Cell survival and plating efficiency were calculated as percentages using the following 
formulae respectively: 
% Cell Survival =  
Number of colonies in experiment flask
Number of cells seeded
× 100 
 
% Plating Efficiency =  
Number of colonies in control flask
Number of cells seeded
× 100 
 
2.9 Time Course for Cell Number 
1 x 105 MCF-7 cells were seeded along with 5ml media in triplicate T25 flasks and were grown 
for 24 hours. The cells were then treated with 25μl of B[a]P, at concentrations 1 x 10-9M and 
1 x 10-6M along with DMSO (as a vehicle control). Four separate cell counts were taken using 
a haemocytometer at 0 hours, 6 hours, 12 hours, 24 hours and 48 hours post treatment. Cells 
were trypsinised, disaggregated and re-suspended prior to cell count. The experiment was 
repeated on three independent occasions. Results were averaged and standard deviation was 
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derived. Time zero (T0) was taken before treatment (0 hours) to normalise cell number to 
100%. Relative cell number was calculated as a percentage using the following formula (Tx 
corresponds to the number of hours): 
Relative Cell Number (%) =  
cell number at Tx
cell number at T0
× 100 
2.10 Flow Cytometry 
1 x 106 MCF-7 cells were seeded in triplicate flasks containing 5ml of media. The cells were 
exposed to nine different cell culture conditions. These included three treatment free controls 
and either S phase or G0/G1 phase concentrated cells treated with three B[a]P concentrations. 
Cells were grown for 24 hours to obtain S phase concentrated cells and 96 hours for G0/G1 
phase concentrated cells. 25μl of B[a]P 1 x 10-9M, 1 x 10-6M and 0M (containing only DMSO as 
a vehicle control) was added to the cells for a 24 hour treatment. Control flasks without 
treatment were fixed after 0 hours, 24 hours and 96 hours incubation. These represent the 
cell cycle distribution at time of seeding and at time of S phase and G0/G1 phase treatment.  
Cells were trypsinised and collected in 15ml centrifuge tubes. They were washed three times 
using 2ml PBS and centrifuged at 1000rpm for 5 minutes. Supernatant was aspirated and the 
cell pellets were subsequently fixed in 2ml ice cold 70% EtOH. This was applied drop-wise over 
a vortex machine to ensure the cells did not cluster together and break up into single cells. 
Samples were then stored at -20°C overnight. The fixed pellet was re-washed twice with PBS 
and centrifuged for 5 minutes at an increased speed of 1500rpm as EtOH presence impedes 
cell precipitation. 50μl of RNase A solution (100μg/ml) was added directly to the cell pellet to 
eliminate RNA presence from the sample. 400μl of Propidium Iodide (PI) (50μg/ml) was then 
added to the cell pellet. The sample was vortexed to mix and left to stain the DNA for 60 
minutes at room temperature. PI is photosensitive so samples were protected from light 
during incubation. Cell pellet was re-suspended in 1.5ml PBS and run through a Becton 
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Dickinson FACSCaliber flow cytometer for analysis. DNA fluorescence was measured in > 
10,000 events and these were processed using the manufacturers FACSDiva Version 6.1.2 
software. The experiment was repeated on two independent occasions. 
2.11 Western Blot 
1 x 106 MCF-7 cells were seeded in triplicate T25 flasks and concentrated in S phase and G0/G1 
phase prior to B[a]P treatment. 25μl of B[a]P at concentrations of 1 x 10-9M, 1 x 10-6M or 0M 
(DMSO) was added to the cells and left for 24 hours. This experiment was repeated four 
separate times staining for either CYP1A1, CYP1A2, P21 or BCL-2. The cells were washed within 
the flask with PBS twice. Cells were then lysed and collected using Radioimmunoprecipitation 
Assay (RIPA) lysis buffer and a cell scraper tool. The collected material was placed in a sonicator 
to allow DNA to break up and proteins to be released. Total protein concentration was 
measured through a Bradford assay with the use of a spectrophotometer. The lowest protein 
concentration was used to equalise of all the sample lysates so that they all carried the same 
amount of protein after being diluted with PBS. Electrophoresis was carried out on a 5-15% 
Bis-Tris gel. 20μl of lysate was added to each well along with a low molecular weight ladder 
(GE Healthcare Limited, Buckinghamshire, UK). The gel was run at 30 volts for 60 minutes. 
Once electrophoresis was completed the gel was blotted onto a Polyvinylidene Difluoride 
(PVDF) membrane cut to 9 cm x 6 cm along with filter paper of the same dimensions. The 
membrane was equilibrated using methanol, distilled water and transfer buffer by soaking it 
for 10 seconds, 2 minutes and 20 minutes respectively. Care was taken to avoid drying out the 
membrane at all times. The gel was blotted at 115 volts for 1 hour. After transfer the PVDF 
membrane was washed with PBS on a rocking platform for 5 minutes. Phosphate-Buffered 
Saline (PBS) was replaced by 20ml of 5% dried skimmed milk dissolved in PBS with 0.1% Tween. 
The membrane was left to probe for one hour on a rocking platform. This step prevents any 
non-specific antibody from binding. Primary and secondary antibody solutions were made up 
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in PBS containing 0.1% Tween and 2% Bovine Serum Albumin (BSA) according to dilution 
guidelines provided by the manufacturers. After probing, the PVDF membrane was placed in 
a 50ml falcon tube together with 5ml primary antibody solution. This was incubated on a 
spiramix overnight at 4°C. The membrane underwent a three stop wash with PBS containing 
0.1% Tween; firstly it was washed for 1 minute followed by two 15 minute washes. PVDF 
membrane was then incubated in 20ml of secondary antibody solution for 1 hour at room 
temperature. Since all primary antibodies were raised in rabbit, an anti-rabbit secondary 
antibody was used. A 3-step wash was again preformed to remove excess antibody presence, 
however pure PBS was used this time. Enhanced Chemiluminescence (ECL) reagent was used 
to visualise the antibodies. 
The origin of the antibodies and their respective dilution concentrations are as follows: anti-
p21 (BD 556431; 1:1000) from BD Science (Oxford, UK), anti-CYP1B1 (CYP1B11-A; 1:50) from 
Alpha Diagnostic (Hampshire, UK), anti-CYP1A1 (ab3568 1:50) was obtained from Abcam 
(Cambridge, MA). The loading control β-actin was visualised using (Ab6276; 1:25,000) from 
Abcam (Cambridge, MA). Secondary anti-rabbit antibody (CST 7074; 1:4000) was from Cell 
Signaling Technologies (Herts, UK). 
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3 Results 
3.1 Endometriosis Results 
The results obtained after spectral analysis, through FTIR-ATR and Raman spectroscopy, of 
endometriosis LBC samples fixed on low-e slides are shown in this section. Individual PCA-LDA 
analysis was carried out for each disease subclass using the pre-processing methods outlined 
in Section 2.4 (Rubber band-Amide I, Rubber band-Vector normalisation, SG differentiation-
Vector normalisation, Polynomial-Vector normalisation). Statistical analysis was carried out to 
determine which pre-processing method best illustrated the variance between subclasses. 
Graphs that illustrate the best results are included in this section along with their 
corresponding table of statistical analysis. The remaining graphs generated through the other 
described pre-processing methods can be found in the appendix B. Rubber band-Amide I is 
shown for FTIR-ATR and Polynomial-Vector normalisation is shown for Raman spectra. 
Statistical analysis of LD1 results (capturing > 90% of data variance) follow a confidence 
interval of 95% where P < 0.05. None of the statistical tables indicate any statistical significance 
for R2. 
3.1.1 Analysis of FTIR-ATR Spectra 
Graphs generated after the PCA-LDA analysis of FTIR-ATR spectra obtained from cervical LBC 
samples are shown in this section. Pre-processing raw spectra using Rubber band – Amide I 
best separated spectra of endometriosis patients from the no endometriosis control patients. 
3.1.1.1 Endometriosis Presence 
Spectra were classed as having either no endometriosis, or having endometriosis. In order to 
use spectroscopy as a diagnostic tool for detecting endometriosis, a strong separation needs 
to be found between the two classes.  
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When interpreting the 1D scatterplot (Figure 19) the data trend line shows the bulk of the data 
for both classes is situated along LD1 around point 0. Initially the two classes appear to contain 
similar variance, yet on closer inspection the trend lines move in opposite directions. 
Endometriosis-free negative control samples drift out to LD1 -0.4 while endometriosis positive 
samples drift towards LD1 0.6. The median values both classes (indicated by the boldest score) 
illustrated a similar shift. The control median is on the lower end of LD1 and the positive 
sample median is more towards higher LD1 values.  
In Vitro and in Vivo Biospectroscopy Applications 
 






Figure 19 – FTIR-ATR spectra obtained from LBC samples of endometriosis and endometriosis free patients (control) were pre-processed with Rubber band-Amide I and analysed through 
PCA-LDA multivariate analysis. A) 1D Scores plot showing PCA-LDA scores along LD1. B) A cluster vector Loading plot showing distinct wavenumbers associated with endometriosis 
presence when compared to coefficient 0 (endometriosis-free control)
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From Table 1 it is clear to see that choosing the correct pre-processing method to analyse data 
is of great importance. Only 1 out of 3 pre-processing methods show that there is a significant 
difference between endometriosis and endometriosis-free control sample spectra. It was due 
to this significance that Rubber Amide I pre-processed data was chosen to be illustrated in this 
section. For Rubber Amide I the P value is < 0.0001, meaning the initial observed shift across 
LD1 carries strong significance.  
 
Table 1 – Table showing statistical analysis of LD1 generated by FTIR-ATR PCA-LDA analysis of endometriosis 
and endometriosis-free control samples. Statistical tests include R2, Unpaired t-Test and F-test. Analysis was 
done on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber band-Vector normalisation and 
SG differentiation-Vector normalisation 
The majority of the peaks shown on the cluster vector graph indicated that endometriosis 
samples greatly differ from the control samples mapped at coefficient 0. The higher the peak, 
the larger the difference. The top eight peaks were labelled and their corresponding 
wavenumbers were added to Table 2. The top peaks and their associations will be looked at 
in more detail in the discussion (Section 4). 
Wavenumber (cm-1) Association 
941 Carotenoid 
1015 
CHα,α’ out-of-plane bending and Cα==Cα’  
torsion 
ν(CO), ν(CC), δ(OCH), ring 
(polysaccharides, pectin) 
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Wavenumber (cm-1) Association 
1150 
C-O stretching vibration 




ν(C-O-C), ring (polysaccharides, pectin) 
1234 
Composed of amide III as well as phosphate 
vibration of nucleic acids 
CH6,2’,α,α’ rock 
1497 C==C, deformation C-H 
1539 
Protein amide II absorption- predominately 
β-sheet of amide II 
Amide II 
1620 
Peak of nucleic acids due to the base carbonyl 
stretching and ring breathing mode 
1717 
C==O thymine 
Amide I (arises from C==O stretching 
vibration) 
C==O stretching vibration of DNA and RNA 
C==O stretching vibration of purine base 
 
Table 2 – Top eight cluster vector peak wavenumbers and their associated chemical identities. Peaks were 
obtained from FTIR-ATR Spectra pre-processed through Rubber band-Amide I and analysed through PCA-LDA 
analysis. The peaks illustrate the wavenumbers that were only detected in patient samples suffering from 
endometriosis compared to endometriosis-free control samples 
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3.1.1.2 Disease Stage 
Analysis was carried out on further disease subclasses to determine how extensive 
spectroscopy can be in identifying and separating disease characteristics. Disease stages 1 to 
4 were analysed. Only one patient sample was classified with having endometriosis at stage 4, 
so the results for this stage are not conclusive as the sample size is too small to be specific. 
In Figure 20 the 1D scores plot shows a distinct linear separation between stages 1, 2 and 3 
along LD1. The median stage scores shift from LD1 0.5 down to -0.1. It would be expected that 
stage 0 (Endometrioses free control) would follow this trend and present itself at around LD1 
0.6. Instead it appears to mirror stage 3, where its median score has an almost identical 
position along LD1. When classes are plotted on the 1D graph along LD2 no distinct differences 
can be observed. Similarly, the 2D graph shows separation across LD1 and not LD2, the ellipse 
walls for stage 3 and stage 0 are almost perfectly overlapping showing a high similarity 
between these two classes. They are better separated along LD3 on the 3D plot. However LD3 
contains the third ranking of capturing most of the data variance (as LD1 captures > 90% of 
variance) so this is not as significant. The loading plot shows minimal peaks representing 
differences between stage 3 and the control class. Stages 1, 2 and 4 have similar peak 
distribution and contain similar wavenumber differences when compared directly to the 
control. 
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Figure 20 – FTIR-ATR spectra obtained from LBC samples of endometriosis and endometriosis free patients (control) were pre-processed with Rubber band-Amide I and analysed through 
PCA-LDA multivariate analysis. Spectra were separated into disease stages 1-4 A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing scores along LD2. C) 2D scores plot 
mapping LD1 along LD2. D) 3D scores plot mapping LD1, LD2 and LD3 containing ellipse walls encapsulating > 95% of the data points. E) A cluster vector loading plot showing distinct 
wavenumbers associated with endometriosis disease stages when compared to coefficient 0 (endometriosis-free control) 
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When testing for statistical significance, multiple tests were used to confirm the initial 
observations (Table 3). Stage 4 shows very little and inconsistent significance throughout the 
pre-processing methods as the dataset size was insignificant. For all of the statistical tests 
applied, in all of the pre-processing methods, a significant difference was determined between 
the all of the different stages. The only exception is when stage 0 is compared to stage 3. 
 
Table 3 –Table showing statistical analysis of LD1 generated by FTIR-ATR PCA-LDA analysis of endometriosis 
stage subclasses. Statistical tests include R2, ANOVA, Tukey’s multiple comparison test and Dunnett’s multiple 
comparison test. Analysis was done on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber 
band-Vector normalisation and SG differentiation-Vector normalisation. Numbers 0-4 indicate disease stage, 
with 0 being no endometriosis presence 
3.1.1.3 Disease Morphology 
The manifestation of lesions during endometriosis can cause great discomfort in patients. Red 
lesions occur in early endometriosis stages and can be removed through ablation. These are 
often overlooked during examination and when given the time to fester they will progress into 
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black lesions as disease stage progresses. Being able to detect red lesions early on could 
prevent the disease from growing into an untreatable state.  
Scores plots across LD1 show that the endometriosis-free control and black + red lesions are 
highly similar (Figure 21). Only red lesion presence is also similar, however, it displays a 
different trend from the control.  Black lesions scores are clearly shifted towards a lower LD1 
when compared to the other classes. The medians plotted on the 1D scores plot across LD2 all 
stay within LD2 0 region. The same can be seen in the 2D and 3D plots, where the majority of 
the separation is observed solely for black lesions along LD1. The cluster vector loading show 
the largest peaks were present for black lesions with respect to the endometriosis-free control 
at coefficient 0. 
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Figure 21 – FTIR-ATR spectra obtained from LBC samples of endometriosis and endometriosis free patients (control) were pre-processed with Rubber band-Amide I and analysed through 
PCA-LDA multivariate analysis. Spectra were separated into disease morphologies of black and red lesion presence. A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing 
scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) 3D scores plot mapping LD1, LD2 and LD3 containing ellipse 
walls. E) A cluster vector loading plot showing distinct wavenumbers associated with endometriosis morphologies when compared to coefficient 0 (endometriosis-free control) 
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After observing a shift in LD1, statistical analysis in confirmed that black lesions were 
significantly different to the control, the red lesions, and the black and red lesions combined 
(Table 4). The latter is surprising as some similarity was excepted since black lesions are 
present in the samples therefore some spectral readings should match up. The dissimilarity of 
the red lesions compared to the black ones might have obscured underlying similarities. No 
other lesions were successfully separated from the control. 
 
Table 4 – Table showing statistical analysis of LD1 generated by FTIR-ATR PCA-LDA analysis of endometriosis 
morphology subclasses. Statistical tests include R2, ANOVA, Tukey’s multiple comparison test and Dunnett’s 
multiple comparison test. Analysis was done on FTIR-ATR data pre-processing through Rubber band-Amide I, 
Rubber band-Vector normalisation and SG differentiation-Vector normalisation. Subclass morphology is 
indicated through letters, with Black lesions (B), Red lesions (R), both black and red lesions (BR) and 
endometriosis-free (0) 
3.1.1.4 Ovarian Endometriosis 
Ovarian endometriosis is one of the more severe manifestations of endometriosis. It is the 
strongest cause of sub fertility induced by endometriosis. The presence of ovarian 
endometriosis scores at stage 3 of disease severity. 
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Figure 22 showing analysed spectra from patients suffering from endometriosis with the 
presence of ovarian endometriosis shows very interesting results. The 1D graphs illustrate that 
the shift between classes only occurs along LD1. The control and the ovarian endometriosis 
free scores show distinctly different trend lines and the medians are widely separated. The 
positive ovarian endometriosis median is very close though the control median along LD1. 
Ovarian endometriosis scores have a compact score range except for one clear outlier on LD1. 
This outlier appears to skews the data trend line and considered to be removed as an anomaly. 
However this same outlier can be seen in the 2D map, on the edge of the no ovarian 
endometriosis ellipse. Here, only a total of 5 ovarian endometriosis positive scores are not 
contained within the red control ellipse. The insignificance of the shift caused by the outlier 
prevented it from being removed to maintain the integrity of the data set. The cluster vectors 
show large peak differences for both classes compared to the control. 
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Figure 22 – FTIR-ATR spectra obtained from LBC samples of endometriosis and endometriosis free patients (control) were pre-processed with Rubber band-Amide I and analysed through 
PCA-LDA multivariate analysis. Spectra were separated into disease morphologies of black and red lesion presence. A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing 
scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data. D) A cluster vector loading plot showing distinct wavenumbers 
associated with endometriosis with and without ovarian endometriosis presence when compared to coefficient 0 (endometriosis-free control) 
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The same statistics results were obtained throughout all of the pre-processing methods (Table 
5). These confirm the observations of LD1 from the graphs. The control is successfully 
separated from samples without ovarian endometriosis, whilst the ovarian endometriosis 
positive samples did not show any significant difference to the control. This shows that 
spectroscopy cannot readily detect ovarian endometriosis. It does reinforce the initial findings 
that endometriosis positive (in this case with no ovarian endometriosis) can be identified from 
no endometriosis control. 
 
Table 5 – Table showing statistical analysis of LD1 generated by FTIR-ATR PCA-LDA analysis of ovarian 
endometriosis. Statistical tests include R2, ANOVA, Tukey’s multiple comparison test and Dunnett’s multiple 
comparison test. Analysis was done on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber 
band-Vector normalisation and SG differentiation-Vector normalisation. Subclass morphology is indicated 
through letters, ovarian endometriosis presence being yes (Y), endometriosis patients without ovarian 
endometriosis are No (N) and endometriosis-free is 0 
3.1.2 Analysis of Raman Spectra 
Graphs generated after the PCA-LDA analysis of Raman spectra obtained from cervical LBC 
samples are shown in this section. Raw data that underwent pre-processing through 
Polynomial-Vector normalisation best separated endometriosis and no endometriosis control. 
Data mirrors results obtained for the FTIR-ATR spectral analysis, this illustrates that 
spectroscopy is a robust characterisation tool. 
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3.1.2.1 Endometriosis Presence 
Endometriosis was successfully identified from the no endometriosis control through IR 
spectroscopy. Vibrational spectroscopy in the form of Raman spectroscopy applied the same 
analysis techniques in order to replicate that success. 
In Figure 23 a similarity can be seen in the data trend line, situated above the scores on the 
graph. The two classes appear similar in shape and distribution, however a definitive shift can 
be seen for the median scores. Endometriosis is shifted towards LD1 -0.2; more so than the 
control.  
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Figure 23 – Raman spectra obtained from LBC samples of endometriosis and endometriosis free patients (control) were pre-processed with Polynomial-Vector normalisation and analysed 
through PCA-LDA multivariate analysis. A) 1D Scores plot showing PCA-LDA scores along LD1. B) A cluster vector Loading plot showing distinct wavenumbers associated with endometriosis 
presence when compared to coefficient 0 (endometriosis-free control). 
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The statistical analysis from the Raman results (Table 6) is comparable to the FTIR-ATR results. 
Again only one pre-processing method shows statistical significant separation between the no 
endometriosis control and the endometriosis samples. Instead of Amide I-Vector 
normalisation the significance is found in Polynomial-Vector normalisation where P < 0.0001. 
 
Table 6 – Table showing statistical analysis of LD1 generated by Raman PCA-LDA analysis of endometriosis and 
endometriosis-free control samples. Statistical tests include R2, Unpaired t-Test and F-test. Analysis was done 
on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber band-Vector normalisation and 
Polynomial-Vector normalisation 
The peaks representing the differences between the classes are very sharp in the loading plot. 
The labeled wavenumbers and their known association have been included in Table 7. These 
will be looked at in more detail in Section 4. 
Wavenumber (cm-1) Association 
500 
C-OH3 torsion of methoxy 
group(1) 
582 OH out of plane bending (free) 
663 
C-S stretching mode of cystine 
(collagen type I) 
783 
DNA 
Thymine, cytosine, uracil 
RNA 
U, T, C (ring breathing modes 
in the DNA/RNA bases) 
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Wavenumber (cm-1) Association 
1552 
Tryptophan 




One of absorption positions 
for the C==O 
stretching vibrations of 
cortisone 
1714 
One of absorption positions 
for the C==O 
stretching vibrations of 
cortisone 
C==O 
1747 C==O, lipids 
 
Table 7 – Top eight cluster vector peak wavenumbers and their associated chemical identities. Peaks were 
obtained from Raman Spectra pre-processed through Polynomial-Vector normalisations and analysed through 
PCA-LDA analysis. The peaks illustrate the wavenumbers that were only detected in patient samples suffering 
from endometriosis compared to endometriosis-free control samples 
3.1.2.2 Disease Stage 
Disease stage represents the quantification of the severity of the disease from 1-4. In this data 
set only one patient had endometriosis stage 4 so the data for this subclass if for illustration 
purposes only as the small sample size does not carry significance. 
In Figure 24, the 1D scores plot a linear shift can be seen for stages 1, 2 and 3 where the scores 
medians are separated steadily along LD1. The endometriosis control can be seen right above 
stage 3 where their medians share the same position along LD1. The ellipse walls for the 
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control contain all the scores plots for stage 3. This same observation has been made for the 
FTIR-ATR analysed spectra. LD1 shift was observed and stage 3 similarities with the control 
were noted. However, no shift was seen in LD2 or LD3. In contrast, the Raman spectra show a 
large shift for stage 1 and 2 along LD2. The loading plot peaks show relatively low peaks for 
stage 3 again. 
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Figure 24 – Raman spectra obtained from LBC samples of endometriosis and endometriosis free patients (control) were pre-processed with Polynomial-Vector normalisation and analysed 
through PCA-LDA multivariate analysis. Spectra were separated into disease stages 1-4 A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing scores along LD2. C) 2D 
scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) 3D scores plot mapping LD1, LD2 and LD3 containing ellipse walls. E) A cluster vector 
loading plot showing distinct wavenumbers associated with endometriosis disease stages when compared to coefficient 0 (endometriosis-free control)
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Endometriosis stage 3 appears to have a similar variance distribution to the endometriosis 
control. When looking at the statistical results for this data (Table 8) it can be seen that 
different methods obtain different results. Stage 4 is extremely varied throughout due to its 
small data set. Overall it appears that disease stages 1 and 2 are significantly different from 
the control. Stage 3 is only significantly different from the control for Rubber vector 
normalisation. However Polynomial Vector Normalisation best separates endometriosis from 
no endometriosis so this is the preferred method. 
 
Table 8 – Table showing statistical analysis of LD1 generated by Raman PCA-LDA analysis of endometriosis 
stage subclasses. Statistical tests include R2, ANOVA, Tukey’s multiple comparison test and Dunnett’s multiple 
comparison test. Analysis was done on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber 
band-Vector normalisation and Polynomial-Vector normalisation. Numbers 0-4 indicate disease stage, with 0 
being no endometriosis presence 
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3.1.2.3 Disease Morphology 
Lesions progress from red, more mild and hidden lesions into hard rooted black lesions that 
are difficult to treat. Analysis on this disease subclass was performed and compared to the 
results obtained through FTIT-ATR. 
It appears that for this data set (Figure 25) there is a slight shift along LD1 as the scores 
medians do not overlap. In LD2 however there is a much greater similarity in the graph plot. 
Red as well as black lesions have shifted towards LD1 -0.45. A distinct cluster of scores plots 
can be seen for Red scores, especially along LD1. 
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Figure 25 – Raman spectra obtained from LBC samples of endometriosis and endometriosis free patients (control) were pre-processed with Polynomial-Vector normalisation and analysed 
through PCA-LDA multivariate analysis. Spectra were separated into disease morphologies of black and red lesion presence. A) 1D Scores plot showing scores along LD1. B) 1D scores plot 
showing scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) 3D scores plot mapping LD1, LD2 and LD3 containing 
ellipse walls. E) A cluster vector loading plot showing distinct wavenumbers associated with endometriosis morphologies when compared to coefficient 0 (endometriosis-free control)
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Statistical tests in Table 9 show that all of the disease morphology classes are significantly 
different to one another. This is shown for all of the pre-processing methods. The exception is 
for red lesions compared to black lesions, where no difference was observed. This is a different 
result than was obtained by FTIR-ATR, which showed a difference between these two classes. 
 
Table 9 – Table showing statistical analysis of LD1 generated by Raman PCA-LDA analysis of endometriosis 
morphology subclasses. Statistical tests include R2, ANOVA, Tukey’s multiple comparison test and Dunnett’s 
multiple comparison test. Analysis was done on FTIR-ATR data pre-processing through Rubber band-Amide I, 
Rubber band-Vector normalisation and Polynomial-Vector normalisation. Subclass morphology is indicated 
through letters, with Black lesions (B), Red lesions (R), both black and red lesions (BR) and endometriosis-free 
(0) 
3.1.2.4 Ovarian Endometriosis 
Patients are often diagnosed with ovarian endometriosis when they experience fertility issues. 
This disease characteristic is very severe and will be classified into the endometriosis a stage 
3 or 4. 
The 1D scores plot in Figure 26 shows a true difference between the three classes along LD1. 
When looking at LD2 no separation can be seen at all. The 2D scores plot shows that there is 
a large difference between the control and the endometriosis no ovarian sample. The ovarian 
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endometriosis positive scores are all held within the 95% ellipse for the no endometriosis 
control. While the endometriosis samples without ovarian endometriosis are much better 
separated. Loading plots illustrate a similar difference between endometriosis samples with 
and without ovarian endometriosis presence.  
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Figure 26 – Raman spectra obtained from LBC samples of endometriosis and endometriosis free patients (control) were pre-processed with Polynomial-Vector normalisation and analysed 
through PCA-LDA multivariate analysis. Spectra were separated into disease morphologies of black and red lesion presence. A) 1D Scores plot showing scores along LD1. B) 1D scores plot 
showing scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data. D) A cluster vector loading plot showing distinct 
wavenumbers associated with endometriosis with and without ovarian endometriosis presence when compared to coefficient 0 (endometriosis-free control)
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Statistical analysis of LD1 shown in Table 10 indicated P value < 0.01 or < 0.0001 when 
comparing samples. This determines that there is strong statistical significant difference 
between all of the samples, despite the similarity between the endometriosis-free control and 
the endometriosis with ovarian presence observed in the PCA-LDA scores plots.  This again 
confirms that samples containing endometriosis can be successfully identified from 
endometriosis free samples, this shows great promise for the diagnostic potential of Raman 
spectroscopy 
 
Table 10 – Table showing statistical analysis of LD1 generated by Raman PCA-LDA analysis of ovarian 
endometriosis. Statistical tests include R2, ANOVA, Tukey’s multiple comparison test and Dunnett’s multiple 
comparison test. Analysis was done on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber 
band-Vector normalisation and Polynomial-Vector normalisation. Subclass morphology is indicated through 
letters, ovarian endometriosis presence being yes (Y), endometriosis patients without ovarian endometriosis 
are No (N) and endometriosis-free is 0 
3.2 MCF-7 Cell Results 
The effect of B[a]P exposure of MCF-7 cells was tested using several experimental methods. 
Different doses of B[a]P were tested for toxicity in the a clonogenic assay in Section 3.2.1. A 
time course assay analysed the proliferation kinetics of MCF-7 cells after B[a]P exposure in 
Section 3.2.3. The flow cytometry data demonstrating the cell cycle position of the MCF-7 cells 
during different times of B[a]P exposure is shown in Section 3.2.3. Protein expression was 
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quantified by western blot analysis in section 3.2.4. Error bars depicting standard deviation 
values have been included on all graphs. 
The results obtained after analysis of MCF-7 samples through FTIR-ATR and Raman 
spectroscopy are shown in Section 3.2.5 and 3.2.6. PCA-LDA analysis was carried out to 
generate scores plots included in this section along with their corresponding table of statistical 
analysis on LD1. Statistical tests follow a confidence interval of 95% where P < 0.05.  
Spectral analysis underwent three combinations of pre-processing methods outlined in 
Section 2.4 (Rubber band-Amide I, Rubber band-Vector normalisation and SG differentiation-
Vector normalisation). As all three pre-processing methods illustrated the same statistical 
significance and cohesive trends for the data set, all of the generated graphs are shown to 
illustrate the robustness of the data. The statistical tests used follow a confidence interval of 
95% where P < 0.05 
3.2.1 B[a]P Toxicity 
The dose response curve obtained after a 7 day treatment of increasing B[a]P concentrations 
shows that B[a]P has an immediate and strong effect on MCF-7 cell survival (Figure 27). A 
distinct relationship can be seen between B[a]P concentration and decreasing cell survival 
percentage. Not a single cell survived the highest treatment dose of 1μM.  
Plating efficiency was calculated to be an average of 10.8%. A total of 500 cells were seeded 
for treatment and approximately 54 colonies were counted at day 7. Whilst colonies account 
for a large number of single cells, the low plating efficiency indicates that DMSO in itself may 
have a toxic effect on cell survival. 
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Figure 27 – Graph illustrating the dose response of MCF-7 cells following a 7 day B[a]P treatment. DMSO is 
used as a vehicle control for B[a]P concentration 0μM, where cell survival is normalised to 100%. Percentage 
Cell Survival = (no. colonies in experiment flask/ no. cells seeded) x 100. Error bars depict the standard 
deviation 
3.2.2 Time Course Analysis of Cell Number 
Quantification of relative cell number progression over a time period of 48 hours (Figure 28) 
allowed for a more in depth view of the proliferation response of MCF-7 cells exposed to B[a]P. 
There is a similar trend followed both by the control and the low B[a]P dose. Cells steadily 
increase in cell number over time and this accumulation speeds up as cells reach their 
exponential growth phase at the 24 hour time point. The low B[a]P dose mimics the clonogenic 
assay results in showing an overall slightly reduced cell number compared to the DMSO 
control. 
There is however a unmistakable contrast presented by the high B[a]P dose. It shows an 
increased relative cell number percentage when compared to the control and the low dose. 
This is apparent for the initial 24 hours. After this the cell number does not just plateau but 
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concentrations have a greater cell number than the control. These results outline the 
importance of the cell cycle for this study. 
 
Figure 28 – Graph showing the effect of B[a]P treatment on MCF-7 cells over a period of 48 hours. Cells were 
treated with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. Relative cell 
number was calculated as a percentage [%; i.e., ratio of the cell number at indicated time point relative to that 
determined at (normalised to 100%) x100]. Standard deviation can be visualised in the error bars 
3.2.3 Identification of Cell Cycle Phase 
Cells were run through a flow cytometer to determine MCF-7 cell cycle distribution. The results 
are presented in bar graphs in Figures 29, 30, and 31. The distribution of G0/G1 phase, S phase 
and G2/M phase is visualised as a percentage. Culture conditions refer to the amount of time 
cells were grown post seeding. Treatment conditions outline the B[a]P concentrations. Cell 
cycle distribution of cells at time of seeding can be seen in the 0 hour control. Standard 
deviation was calculated and can be visualised through the error bars. 
Control measurements were taken to check that 24 and 96 hours were the appropriate time 
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most cells were found to be in early G phase (G0/G1). Cells grown for 96 hours were successfully 
shown to contain the majority of cells in G0/G1 phase. Growing cells for 24 hours greatly 
increased the percentage of cells located in S phase. Even though the cell cycle distribution 
was equal for all the phases, this is the highest observed S phase distribution and lowest G 
phase distribution.  
 
Figure 29 – Graph showing the cell cycle distribution of MCF-7 cells before treatment of B[a]P. Cells were grown 
for 0 hours, 24 hours and 96 hours before being analysed by flow cytometry. Cells are distributed in G0/G1, S or 
G2/M phases. The experiment was repeated two independent times with triplicate flasks. Data was averaged 
and error bars were added to depict the standard deviation 
Using the knowledge that 24 hour growth results in S phase concentrated cells, cells were 
treated with a 24 hour B[a]P treatment during S phase (Figure 30). Varying concentrations of 
B[a]P resulted in a different cell cycle distribution. DMSO and a low treatment dose showed 
similar results of a high G0/G1 presence and a low even distribution of S and G2/M phase. A 
high concentration of B[a]P showed a very different result. It echoes the findings of the time 
course experiment, where the low B[a]P dose and the control are similar, whilst only the high 
dose elicits a change. The percentage of cells located in S phase greatly increases for B[a]P 10-
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incubation (when a third of the cell population is in S phase) cells gain the ability to surpass 
G0/G1 more easily and therefore show an increased presence in S phase. 
 
Figure 30 – Graph showing the cell cycle distribution of MCF-7 cells after a 24 hour treatment of B[a]P. Cells 
were grown for 24 hours (concentrated in S phase) then treated with concentrations of 10-9M B[a]P, 10-6M 
B[a]P or a DMSO only control and subsequently analysed by flow cytometry. Cells are distributed in G0/G1, S or 
G2/M phases. The experiment was repeated two independent times with triplicate flasks. Data was averaged 
and error bars were added to depict the standard deviation 
When G0/G1 phase concentrated cells were treated with B[a]P very minimal difference was 
observed between the varying treatment concentrations (Figure 31). All three conditions 
showed an overwhelming G0/G1 presence. A slight shift of cell percentage distribution can be 
seen from G0/G1 into S phase when cells treated with a high B[a]P dose. Yet the large error 
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Figure 31 – Graph showing the cell cycle distribution of MCF-7 cells after a 24 hour treatment of B[a]P. Cells 
were grown for 96 hours (concentrated in early G0/G1 phase) prior to the treatment with concentrations of 10-
9M B[a]P, 10-6M B[a]P or a DMSO only control and then analysed by flow cytometry. Cells are distributed in 
G0/G1, S or G2/M phases. The experiment was repeated two independent times with triplicate flasks. Data was 
averaged and error bars were added to depict the standard deviation 
3.2.4 Protein Expression 
A western blot was preformed to examine how different concentrations of B[a]P was affecting 
protein expression when applied to cells in S phase and G0/G1 phase (Figure 32). This was done 
in the hope to uncover a better understanding of the molecular mechanisms occurring during 
the observed S phase proliferation phenomenon induced by a high dose of B[a]P.  
Protein expression can be seen for CYP1A1 during S phase and G0/G1 phase. Its presence is 
observed when B[a]P is exposed to G0/G1 phase concentrated cells. It is also seen in S phase 
at both concentrations. However, in the replicates, either of the concentrations expressed 
CYP1A1. This, coupled with the poor β-actin blot, brings into question the validity of this data. 
It can be observed that CYP1B1 is clearly expressed in G0/G1 phase cells. This is true for all 
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The high dose of B[a]P expressed the most. During S phase, a reduced protein expression was 
observed. However, it is faintly present throughout the treatment concentrations with the 
darkest band observed at the DMSO control. It seems S phase and G0/G1 phase show 
conflicting results. 
P21 expression is extremely faint. However, a slight band can be seen in the high dose 
treatment for both S phase and G0/G1 phase concentrated cells. Again, a poor β-actin blot 
disputes the validity of this data and explains the weak band intensity for P21. 
For BCL-2, the low molecular weight ladder showing a band at 25kDA was chosen to be 
included in the western blot results. Whilst no bands can be seen at 26kDA, some can be 
observed just below the 25kDA band. According to the β-actin staining the blot was very 
successful. Therefore it can be determined that no BCL-2 presence was expressed in any of the 
treatment and culture conditions. 
BCL-2 expression is coupled with P21 expression and the expectation is to observe down 
regulation of P21 when BCL-2 is overexpressed. Since no BCL-2 was detected, it can be 
concluded that the P21 western blot would require repeating, as it was not suppressed by BCL-
2 presence. 
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Figure 32 – Western Blot showing CYP1A1, CYP1B1, P21 and BCL-2 protein expression. The 25kDa band can be 
seen in the first well of BCL-2. Culture conditions include C= DMSO control, -6 = B[a]P 10-6M and -9 = B[a]P 10-
9M. Duplicate blots can be seen as repeat 1 and repeat 2. Β-actin expression was measured at 42kDa and can 
be seen on the lower half of the figure 
3.2.5 Analysis of FTIR-ATR Spectra 
Graphs generated after the PCA-LDA analysis of spectra obtained through FTIR-ATR 
spectroscopy on MCF-7 cells fixed on low-e slides are shown in this section. MCF-7 cells were 
concentrated in either S phase or G0/G1 prior to a 24h treatment with either DMSO (control), 
B[a]P 10-9M or B[a]P 10-6M. Graphs obtained after PCA-LDA analysis are shown below along 
tables showing statistical evaluation of LD1 results (capturing > 90% of data variance). 
Statistical tests follow a confidence interval of 95% where P < 0.05.  Three different pre-
processing methods were applied to the data set before PCA-LDA analysis, these include 
Rubber band-Amide I, Rubber band-Vector normalisation and SG differentiation-Vector 
normalisation. All three pre-processing methods resulted in near identical results. 
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3.2.5.1 S Phase Concentrated Cells 
S phase concentrated MCF-7 cells treated with varying B[a]P concentrations underwent 
spectral analysis to determine if B[a]P induces a changes in the biochemical fingerprint  of 
sample when treated at a specific point in the cell cycle. Previous results indicate a significance 
of the S phase when a high B[a]P treatment is applied. 
In Figure 33 (Rubber band-Amide I), Figure 34 (Rubber band-Vector normalisation) and Figure 
35 (SG differentiation-Vector normalisation) a distinct separation can be seen for the highest 
dose of B[a]P compared to the DMSO control and B[a]P 10-9M across LD1. A shift is observed 
towards LD1 -0.1 whilst the lower dose and the control stay by LD1 0.1. In the 2D scores plot 
only two scores connect the 95% ellipse of B[a]P 10-6M to the control and in SG differentiation-
Vector normalisation these two conditions are separated entirely across LD1 and LD2. 
When comparing the DMSO control to the low Dose of B[a]P, a definite overlap can be seen 
across LD1 on both the 1D and 2D scores plots. This is the lease for SG differentiation-Vector 
normalisation best separated these treatment conditions, interesting it is the only pre-
processing method that illustrated a shift across LD2. The B[a]P treatments both shift towards 
LD2 0.01 compared to the control at LD2 -0.01. 
The cluster vector illustrates very large peaks for the B[a]P 10-6M when set against DMSO 
control (coefficient 0), smaller but seemingly significant peaks can be seen for B[a]P 10-9M.
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Figure 33 – FTIR-ATR spectra obtained from S phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. Spectra 
were pre-processed with Rubber band-Amide I and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing scores along 
LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct wavenumbers associated 
with B[a]P treatment when to coefficient 0 (DMSO control) 
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Figure 34 – FTIR-ATR spectra obtained from S phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. Spectra 
were pre-processed with Rubber band-Vector normalisation and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing 
scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct wavenumbers 
associated with B[a]P treatment when to coefficient 0 (DMSO control) 
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Figure 35 – FTIR-ATR spectra obtained from S phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. Spectra 
were pre-processed with SG differentiation-Vector normalisation and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot 
showing scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct 
wavenumbers associated with B[a]P treatment when to coefficient 0 (DMSO control)
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The initial observed separation along LD1 of B[a]P 10-6M treated cells from the control, DMSO 
only treated cells, is validated through statistical analysis in Table 11. It confirms that the high 
dose of B[a]P is significantly different to the control and the low dose B[a]P, with a P value < 
0.001. It also shows that the DMSO control and the low B[a]P dose can be significantly be 
separated from each other despite their scores plots overlap. 
 
Table 11 - Table showing statistical analysis of LD1 generated by FTIR-ATR PCA-LDA analysis on S phase 
concentrated MCF-7 cells treated with B[a]P. Statistical tests include R2, Unpaired t-Test and F-test. Analysis 
was done on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber band-Vector normalisation 
and SG differentiation-Vector normalisation. Treatment conditions are indicated through letters, where C = 
DMSO control. -9 = B[a]P 10-9M. -6 = B[a]P 10-6M 
3.2.5.2 G0/G1 Phase Concentrated Cells 
MCF-7 cells concentrated in G0/G1 phase and treated with B[a]P at concentrations of 10-9M 
and 10-6M underwent spectral analysis to determine if B[a]P susceptibility varies when cells 
are treated at different stages in the cell cycle.  
Figures 36 (Rubber band-Amide I) Figure 37 (Rubber band-Vector normalisation) and Figure 
38 (SG differentiation-Vector normalisation) show a clear separation between all three 
treatment conditions. There is a gradual shift along LD1 as the concentrations are becoming 
increasingly different, this is apparent in the 1D and the 2D scores plots. Interestingly the 
ellipse walls (with a 95% confidence interval) show that the B[a]P dose of 10-9M is entirely 
contained within the region of overlap between the control and B[a]P 10-6M. No separation of 
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treatment conditions can be observed along LD2. The cluster vector displays a similar trend 
where the higher the B[a]P dose, the larger the peak.   
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Figure 36 – FTIR-ATR spectra obtained from G0/G1 phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. 
Spectra were pre-processed with Rubber band-Amide I and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing scores 
along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct wavenumbers 
associated with B[a]P treatment when to coefficient 0 (DMSO control) 
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Figure 37 – FTIR-ATR spectra obtained from G0/G1 phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. 
Spectra were pre-processed with Rubber band-Vector normalisation and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot 
showing scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct 
wavenumbers associated with B[a]P treatment when to coefficient 0 (DMSO control) 
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Figure 38 – FTIR-ATR spectra obtained from G0/G1 phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. 
Spectra were pre-processed with SG differentiation-Vector normalisation and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores 
plot showing scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct 
wavenumbers associated with B[a]P treatment when to coefficient 0 (DMSO control) 
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Table 12 shows that all treatment conditions carry significant statistical difference and can be 
separated successfully with a P value < 0.001. The P value results for this data is identical to 
the data obtained for S phase treated cells. The only difference between cells treated in S 
phase and G0/G1 phase is the visual trend observed in the scores plots where S phase shows 
to be susceptible to only the high, B[a]P 10-6M, dose. This trend is not statistically significant 
and can therefore be disputed.  
 
Table 12 – Table showing statistical analysis of LD1 generated by FTIR-ATR PCA-LDA analysis on G0/G1 phase 
concentrated MCF-7 cells treated with B[a]P. Statistical tests include R2, Unpaired t-Test and F-test. Analysis 
was done on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber band-Vector normalisation 
and SG differentiation-Vector normalisation. Treatment conditions are indicated through letters, where C = 
DMSO control. -9 = B[a]P 10-9M. -6 = B[a]P 10-6M 
3.2.6 Analysis of Raman Spectra 
Graphs generated after the PCA-LDA analysis of spectra obtained through Raman 
spectroscopy on MCF-7 cells fixed on low-e slides are shown in this section. MCF-7 cells 
concentrated in S phase or G0/G1 phase underwent a 24hour treatment with either a DMSO 
(control), B[a]P 10-9M or B[a]P 10-6M. Graphs generated after PCA-LDA analysis are shown 
below together with tables showing statistical evaluation of LD1 results. Statistical tests follow 
a confidence interval of 95% where P < 0.05. 
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3.2.6.1 S Phase Concentrated Cells 
Raman spectroscopy was applied to MCF-7 cells concentrated in S phase and subsequently 
treated with varying concentrations of B[a]P. Spectral analysis through PCA-LDA resulted in 
the graphs shown in Figures 39 (Rubber band-Amide I) Figure 40 (Rubber band-Vector 
normalisation) and Figure 41 (SG differentiation-Vector normalisation). S phase concentrated 
cells have been shown to have a higher susceptibility to B[a]P’s genotoxic effects. 
Only a slight shift across LD1 can be seen between the different treatment conditions in the 
1D and 2D scores plots. This is mainly apparent for the high dose B[a]P which is partially 
separated from the low dose B[a]P and the control (DMSO only). No shift is visible across LD2 
as all three conditions remain parallel. On the 2D scores plot, the ellipse walls overlap 
significantly, with the entire control ellipse being contained within the B[a]P 10-9M ellipse 
walls. It is clear that only the high dose condition can be separated from the other conditions 
through Raman spectroscopy whilst the control and low dose B[a]P contain very similar 
spectral properties. 
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Figure 39 – Raman spectra obtained from S phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. Spectra 
were pre-processed with Rubber band-Amide I and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing scores along 
LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct wavenumbers associated 
with B[a]P treatment when to coefficient 0 (DMSO control) 
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Figure 40 – Raman spectra obtained from S phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. Spectra 
were pre-processed with Rubber band-Vector normalisation and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing 
scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct wavenumbers 
associated with B[a]P treatment when to coefficient 0 (DMSO control) 
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Figure 41 – Raman spectra obtained from S phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. Spectra 
were pre-processed with SG differentiation-Vector normalisation and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot 
showing scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct 
wavenumbers associated with B[a]P treatment when to coefficient 0 (DMSO control)
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The observations obtained from the scores plots are reinforced through the statistical analysis 
shown in Table 13. The DMSO control (containing no B[a]P) is not found to be significantly 
different than the low dose B[a]P of 10-6M as P > 0.05. The analysed spectra acquired from the 
high B[a]P concentration varies greatly from the control and the low dose, where P < 0.001. 
This is true for all three of the pre-processing methods, as they show coherent results. 
 
Table 13 – Table showing statistical analysis of LD1 generated by Raman PCA-LDA analysis on S phase 
concentrated MCF-7 cells treated with B[a]P. Statistical tests include R2, Unpaired t-Test and F-test. Analysis 
was done on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber band-Vector normalisation 
and SG differentiation-Vector normalisation. Treatment conditions are indicated through letters, where C = 
DMSO control. -9 = B[a]P 10-9M. -6 = B[a]P 10-6M 
3.2.6.2 G0/G1 Phase Concentrated Cells 
When G0/G1 concentrated MCF-7 cells were treated with B[a]P and analysed through Raman 
spectroscopy the results echoed the findings from the S phase concentrated cells. Figures 42 
(Rubber band-Amide I), Figure 43 (Rubber band-Vector normalisation) and Figure 44 (SG 
differentiation-Vector normalisation) contain scores plots and cluster vectors after PCA-LDA 
analysis. 
A very clear shift across LD1 can be observed in the 1D and 2D scores plots. As consistently 
stated, B[a]P 10-6M is strongly separated from the control and 10-9M. The DMSO control and 
low treatment dose are not seemingly different to each other. On the 2D scores plot, the 
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ellipse walls of the DMSO control encapsulate the majority of the scores from the low B[a]P 
dose. The ellipse walls of the high B[a]P dose barely overlap at all with the other scores and 
hereby show a strong separation along LD1. 
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Figure 42 – Raman spectra obtained from G0/G1 phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. 
Spectra were pre-processed with Rubber band-Amide I and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot showing scores 
along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct wavenumbers 
associated with B[a]P treatment when to coefficient 0 (DMSO control) 
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Figure 43 – Raman spectra obtained from G0/G1 phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. 
Spectra were pre-processed with Rubber band-Vector normalisation and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores plot 
showing scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct 
wavenumbers associated with B[a]P treatment when to coefficient 0 (DMSO control) 
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Figure 44 – Raman spectra obtained from G0/G1 phase concentrated MCF-7 cells treated for 24h with concentrations of 10-9M B[a]P and 10-6M B[a]P alongside a DMSO only control. 
Spectra were pre-processed with SG differentiation-Vector normalisation and analysed through PCA-LDA multivariate analysis. A) 1D Scores plot showing scores along LD1. B) 1D scores 
plot showing scores along LD2. C) 2D scores plot mapping LD1 along LD2 containing ellipse walls encapsulating > 95% of the data points. D) A cluster vector loading plot showing distinct 
wavenumbers associated with B[a]P treatment when to coefficient 0 (DMSO control)
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Table 14 shows that P is smaller than 0.0001, therefore a significant difference is observed 
between the control and the B[a]P low dose of 10-9M and also between the two B[a]P 
treatment concentrations. However, the control DMSO and the low B[a]P concentrations 
show distinct similarities. This is again suggested after statistical analysis. Variance found 
between the control and B[a]P 10-9M is only statistically different for the Rubber Band and 
Vector normalisation pre-processed data where is has a P value < 0.01. This carries less 
significance than the P values of < 0.001, obtained when cross comparing control to B[a]P 10-
9M or B[a]P 10-9M to B[a]P 10-6M. 
 
Table 14 – Table showing statistical analysis of LD1 generated by Raman PCA-LDA analysis on G0/G1 phase 
concentrated MCF-7 cells treated with B[a]P. Statistical tests include R2, Unpaired t-Test and F-test. Analysis 
was done on FTIR-ATR data pre-processing through Rubber band-Amide I, Rubber band-Vector normalisation 
and SG differentiation-Vector normalisation. Treatment conditions are indicated through letters, where C = 
DMSO control. -9 = B[a]P 10-9M. -6 = B[a]P 10-6M  
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4.1.1 Detecting Endometriosis 
Whilst separation of endometriosis presence is not immediately apparent from the PCA-LDA 
scores plot, after testing the data for statistical significance, variance was proven to be highly 
significant. Both FTIR-ATR and Raman spectroscopy have shown to be capable of distinguishing 
endometriosis presence within an LBC sample. For both of the applied spectroscopy 
techniques, the obtained P values were < 0.0001 for the unpaired t-test. Raman had slightly 
more sensitivity in detecting endometriosis as its P value was < 0.0001 for the F-test. This was 
only 0.0178 for FTIR-ATR. It is important to note that one out of three pre-processing methods 
was successful in detecting endometriosis for both techniques. These pre-processing methods 
differed for each machine as Raman was successful with Polynomial-Vector normalisation 
whilst FTIR-ATR was successful with Rubber band-Amide I.  The ability to distinguish 
endometriosis presence confirms the notion that cells and tissue from endometriosis are 
histologically different to normal endometrial cells.  
Main peak differences found in FTIR- ATR spectra were found to be associated with nucleic 
acids and DNA/RNA vibration frequencies at 1717cm-1 and 1234cm-1. This suggests that 
endometriosis has a genetic underlying cause. It is possible that the cells have retained some 
stem cell DNA or RNA, allowing them to have an increased plasticity (Laganà et al., 2013) This 
also reinforces the theory of the hereditary link to endometriosis. A difference for Carotenoid 
vibration at 951cm-1 was one of the largest peaks observed. This is very interesting as the 
dietary carotenoid lycopene has been linked to inhibit endometrial cancer (Nahum et al., 
2001). Therefore carotenoid can be considered capable of eliciting an effect in endometrial 
tissue. The role of carotenoid β-carotene in cancer has been long disputed. Some studies show 
that it contains anti-cancerous properties (Peto et al. 1981) however other studies indicate 
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that it plays a major role in the development of cancer (Omenn et al., 1996). It is clear that 
carotenoid is involved in abnormal proliferation of tissue, whether the effect is more 
preventative or causative is yet to be determined. 
Raman spectra uncovered RNA/DNA (783cm-1) and more importantly the 1682cm-1 and 
1714cm-1 regions that are associated with cortisone. Increased levels of cortisone and cortisol 
presence have been previously suggestive of an increased susceptibility to endometriosis (Miki 
et al,. 2014). It is theorised that women with high cortisol levels have a lower immune response 
and are not as capable of removing cell debris deposited by retrograde menstruation (Miki et 
al,2014).  However it is unclear whether the increased cortisol levels are a result of the disease 
causing discomfort and stress, resulting in the release of cortisol from the adrenal gland. 
4.1.2 Similarities between Severe Endometriosis and Control  
Black lesions are a trait linked to endometriosis progression, whilst red lesions appear at early 
stages. The former are more pronounced and easier to detect by eye as well as with FTIR-ATR 
spectroscopy. Black endometriosis was significantly separated from disease free patients, 
whilst red lesions were not shown to be significantly dissimilar to the control. It is not 
surprising that early symptoms of endometriosis have more spectral similarities to patients 
without endometriosis, as smaller regions will be affected and the lesions are not as 
established.  
When red and black lesions were analysed using Raman spectroscopy, no significance was 
found between the control and any type of lesion. However, Raman spectroscopy showed to 
have the delicate ability to actually differentiate between a black and a red region.  Both 
spectral techniques have shown an incredible cohesion between results obtained. It is only in 
lesion detection that a strong difference was found between the techniques. 
An interesting finding is that no dissimilarity was observed when control samples were directly 
compared to samples suffering from some of the more severe characteristics of 
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endometriosis. This was found for patients in disease stage 3 and for those with ovarian 
endometriosis presence (in FTIR-ATR). This is curious, as it is expected that disease progression 
would become increasingly apparent and more easily detectable. The presence of black lesions 
and ovarian endometriosis are often found during the later disease stages 3 or 4. It coincides 
with the finding that ovarian endometriosis presence was much harder to distinguish from the 
endometriosis free samples, the same way stage 3 was harder to distinguish. However, in 
contrast to this black lesions were the only lesions that were successfully separated from the 
control (for FTIR-ATR only).  A possible explanation for this is that endometriosis symptoms do 
not directly correlate with disease stage. The stage categorisation is a subjective guideline for 
doctors, and black lesions can also be found in earlier stages where patients have few other 
symptoms. Detecting ovarian endometriosis, however, is very severe and even if this is the 
only disease phenotype the patient will be will be classified with stage 3. In this particular 
sample group all of the ovarian endometriosis positive patients were classified at stage 3.  
The similarity between separation difficulty for stage 3 and ovarian endometriosis presence 
can be explained through the fact that endometriosis severity does not correlate to specific 
phenotypes. When separating stage 3 spectra from the control and when separating ovarian 
endometriosis presence from the control, the same spectral variance will be observed because 
the two classes fall into the same category. 
However, the observed similarity between severe endometriosis samples (disease stage 3 and 
ovarian endometriosis presence) and endometriosis free samples brings into question the 
underlying cause of the disease. One explanation could be down to endometriosis density. 
Whilst endometriosis tissue is histologically different from endometrium tissue, it is possible 
that as this tissue becomes more established it will more closely resemble endometrial tissue 
as its structures are becoming more pronounced. 
In Vitro and in Vivo Biospectroscopy Applications 
 
113 | P a g e  
 
It could be seen as detrimental that more severe endometriosis proves to be more difficult to 
distinguish. However, this incidentally means that even very primitive endometriosis at stage 
1 is more easily detected. This shows promise for spectroscopy to be used as an early screening 
tool, allowing women to be diagnosed at earlier stages, when the disease is most likely to be 
overlooked. Catching endometriosis early allows for much more successful treatment options. 
It is more valuable and efficient to detect the disease at its early stages rather than later when 
it is more established. 
4.1.3 Challenges 
This study applied several different pre-processing methods to spectral acquisitions in order 
to separate class variance as a tool for detecting endometriosis. A significant difference was 
detected between subclasses. However, pre-processing methods that best separated the 
classes differed for each endometriosis characteristic. Whilst the potential to use spectroscopy 
as a high throughput and low cost diagnostic tool is apparent, its application needs to be 
further refined. To allow for widespread use of this technique in hospital laboratories, 
consistency is required to select a suitable pre-processing method for data analysis. 
When a patient sample is screened for endometriosis, this would have to be compared to a 
spectral database with information on other endometriosis sufferers. Using a shared open 
access database carries a challenge, as patient data is regarded as confidential and ethical 
regulations need to be taken into consideration. Different spectroscopy machines used during 
sample screening will require their own specific databases.  
Both Raman and FTIR-ATR spectroscopy showed specificity when separating endometriosis 
presence. While both machines can be used for screening, data needs to be compared to the 
database built specifically to each machine. A simpler solution would be if only one database 
was created. This would, however, limit the number of laboratories able to participate in 
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screening, as only the ones with the correct machine would have the ability to compare their 
spectra to the database. 
43 patient samples were compared in this study. In order for the shared database to carry a 
high specificity and sensitivity rate, a much larger data set is required. Having a higher number 
of control samples would contribute to reduced false positive diagnoses. This notion comes 
hand-in-hand with the challenge faced with diagnosing endometriosis in the first place, as 
there is a possibility that many of the control patients actually have endometriosis. This 
presence would reduce the reliability of the dataset, as control spectra obtained would be 
contaminated. 
As an increasing number of cervical cancer screening is being performed through spectral 
analysis of LBC samples. If the spectra acquired from these samples were to be run though the 
endometriosis database, women would have access to conclusive endometriosis screening 
and diagnoses at an almost negligible cost. Whilst this is a great opportunity, implementing a 
nationwide screening through spectroscopy has already proven to be challenging (Gajjar et al., 
2014) as not all laboratories are properly equipped. Governmental action would be required 
in order to establish new screening laws; a process that could be extremely time consuming. 
Due to endometriosis being prevalent throughout the entire body, future challenges involve 
being able to detect endometriosis in areas outside the pelvic cavity. Surface-Enhanced Raman 
Spectroscopy (SERS) could be applied to the samples to enhance spectral readings, although 
this can is very costly. SERS is a technique that uses metal surfaces, most commonly silver and 
gold, to increase the signal to noise ratio by enhancing the amount of Raman scattering 
detected (Butler et al., 2015). 
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4.2 MCF-7 Cells 
4.2.1 B[a]P Dose Response 
The clonogenic assay was conclusive and showed that DMSO in itself has an effect on MCF-7 
cell survival since the plating efficiency was very low. It can be said that counting stained 
colonies by eye carries a large bias. However from the error bars contained in Figure 27 it is 
clear that despite choosing to count only large colonies, consistency ensured equal measures 
were taken for all of the experimental flasks. MCF-7 cells show to have a strong linear dose 
response when treated with B[a]P as percentage cell survival drastically decreases as B[a]P 
concentration increases. Cells exhibit a slight reduction in plating efficiency which accounts for 
the toxic properties of the vehicle control DMSO itself. 
4.2.2 Cell Number Over Time 
The observed increase in cell number for a high dose B[a]P compared to the control is a 
contradiction, as B[a]P should damage the cells and decrease proliferation. B[a]P induced CYP1 
isoforms cause increased proliferation as a way of encouraging damaged and mutated cells to 
finish the cell cycle and become abundant (Harper et al., 2010). This provides and explanation 
for increased proliferation after B[a]P treatment. 
4.2.3 Cell Cycle Progression 
The 0 hour control indicated that at the time of seeding 63.4% of the cells were in G0/G1 phase. 
The remaining 36.6% of the population was distributed evenly through S and late G2 phase. 
This greatly resembles the population distribution of cells found in a 96 hour growth culture. 
G0/G1 phase is a clear outlier and over half the population resides in this phase. MCF-7 cells 
cultured for 24 hours are found to be very evenly distributed within the cell cycle phases. It is 
surprising that cells in S phase are twice as present. 
These findings illustrate the reasoning behind choosing to culture cells for 24 hours and 96 
hours respectively in order to concentrate cells in either S or G2/M phases.  When referring to 
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an S phase concentrated culture, this refers to the 24 hour point in which the highest presence 
of cells in S phase is observed. Whilst this only accounts for 31.9% of the population, it relates 
to a third of the population.  
Cells that were grown for 24 hours prior to B[a]P treatment were concentrated in S phase. 
Following a 24 hour treatment, the cell cycle distribution appears similar to 0 hour and 96 hour 
cultures, where G0/G1 phase dominates over half of the population and S and G2/M account 
for the remaining 40% evenly. However, cells treated with a high dose of 10-6M B[a]P showed 
a steep incline in S phase concentrated cells. S phase concentrated cells treated with DMSO 
control do not show an even distribution of all phases. Instead, approximately 40% of the cells 
are in G0/G1 or S phase, whilst only 13% are found in G2/M. This same effect does not occur 
with a lower B[a]P concentration. 
The clonogenic assay indicated that B[a]P elicits a reduction in cell survival when applied to 
MCF-7 cells, it appears that only a higher concentration is able to induce cell cycle alterations. 
This is both observed through flow cytometry as well as the time course assay. Both 
experiments showed a strong response in the S phase/ 24 hour window. 
When a 24 hour B[a]P treatment was applied to G0/G1 phase concentrated cells (grown for 96 
hours), very little difference between treatment conditions was observed. There was only a 
slight increase of S phase and G2/M phase when the cells were exposed to 10-6M B[a]P 
compared to the DMSO control and lower B[a]P dose. This was within the range of the 
standard deviation error bars, meaning it does not carry much significance. Around 70 to 80% 
of the cells were present in G0/G1 phase throughout all treatment conditions. 
4.2.4 S Phase Accumulation 
When the accumulation is observed in S phase, this is due to a high number of cells having 
passed the restriction point and avoiding G1 arrest/ G0 quiescence. Therefore, more cells are 
passed on and get detected in S phase. Cells are continuously able to re-enter the cell cycle 
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despite damage, causing a high number of faulty cells to complete the cell cycle. This in turn 
gives them the ability to continuously re-enter the cell cycle, resulting in unregulated growth 
and proliferation capacity commonly seen in tumours. It is also possible that the cells have 
successfully surpassed the checkpoint and have passed into S phase where they are 
accumulating as there are further checkpoints employed within S phase (Ye et al., 1996). 
4.2.5 Complementary Spectra 
Results obtained through PCA-LDA and statistical analyses were very similar for FTIR-ATR and 
Raman spectra throughout the three pre-processing methods used. This indicates that FTIR-
ATR and Raman spectroscopy are complementary to one another and can be used in unison. 
Raman analysis concluded that there was no difference between low dose B[a]P and the 
DMSO control. FTIR-ATR did identify a difference between all of the treatment classes. The 
separation of classes reinforces the accuracy of subcellular detection in both vibrational and 
infrared spectroscopy. Consistent results were obtained through Raman and FTIR-ATR 
spectroscopy when analysing MCF-7 cells. Both spectroscopy techniques were able to 
differentiate between cells treated with B[a]P in S phase and G0/G1 phase. No cell cycle phase 
difference was observed through biospectroscopy in this study, even though the flow 
cytometry and time course assay reinforce the notion that cell cycle phase affects B[a]P 
effects. Loading plots identified wavenumber regions associated with lipids and specifically 
with DNA vibrations when cells were treated with B[a]P. These tables are shown in the 
appendix D. Here is apparent that more DNA vibrations were observed when cells were 
treated in S phase. 
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5 Conclusion 
Spectroscopy is a very sensitive tool which carries the ability to analyse both in vitro and in 
vivo cells. Raman and FTIR-ATR spectroscopy are compatible as they showed very similar 
results, even after undergoing different pre-processing methods. This was true for both 
endometriosis detection and MCF-7 examination.  
Endometriosis can successfully be detected from a no endometriosis control. This is very 
promising for the medical field as it can provide a non-invasive, high throughput and high 
specificity diagnostic tool. The Tao Brush offers a comfortable way of obtaining an 
endometrium sample that can be used for multiple screenings. The implementation of LBC 
would open up many more screening opportunities in the UK and offers a conclusive 
diagnostic method without the need for surgery. Raman spectroscopy proved to be the most 
successful in detecting endometriosis. It was able to recognise endometriosis presence with 
very high significance. It could distinguish between different stages, expect for late stage 3 
(same as FTIR-ATR). It was able to detect spectral differences between red and black lesions, 
and even found variance for endometriosis in the ovaries. Progressive endometriosis appears 
to carry a biochemical fingerprint similar to control samples without endometriosis for ATR 
spectra. It is unclear if this is a trait of the disease pathology, or if IR spectroscopy lacked 
specificity.  
As for the MCF-7 cell cycle study of toxicity, research project demonstrates that B[a]P is 
capable of inducing alterations in exposed cell populations even at very low doses. B[a]P 
gradually reduces cell survival after 7 days exposure. However, when exposed for 6 to 24 
hours, when the cells are completing S phase, a high dose of 10-6 M B[a]P induces short term 
increased proliferation and accumulation in S phase. After 24 hours the long term inhibition 
of cell growth caused by B[a]P is re-established. Flow cytometry showed evidence that the 
cells are in the presumed cell cycle phases. Biospectroscopy analysis (FTIR-ATR and Raman) 
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clearly distinguished between cells that have been concentrated in G0/G1 and S phase and 
exposed to B[a]P concentrations of 10-9M and 10-6M. Despite being affected by B[a]P, the cells 
are able to survive. The surviving cells suffered from altered protein expression, in particular 
CYP1B1 involved in xenotic metabolism of B[a]P.  
Overall this study showed that spectroscopy is a novel tool that has multiple biological, 
chemical and physical applications. Its benefits are the non-destructive and non-invasive 
nature of the acquisition procedure, and it is a technique which needs to be exposed to further 
research in order to uncover its full potential. 
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7 Appendix 
Additional graphs, tables and other supplementary information can be found here. 
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Appendix A – Poster presented at the European Environmental Mutagenesis Society (EEMS) 




How different concentrations of B[a]P affect MCF-7 cells 
v MCF-7 cells were cultured in complete DMEM medium 
v 500 cells seeded per T25 flask 
v Added 25μl of  B[a]P concentrations 
v Used DMSO as a vehicle control 
v Treated for 7 days 




As B[a]P concentration increases the % cell survival decreases. 




How B[a]P exposure time affects proliferation of MCF-7 cells 
v MCF-7 cells were cultured in complete DMEM medium 
v 10000 cells seeded per T25 flask, grown for 24h 
v Added 25μl of  B[a]P/DMSO concentrations 
v Treated for 0h, 6h, 12h, 24h and 48h 
v After treatment cells were disaggregated with trypsin, centrifuged  
v    and re-suspended in complete DMEM 




Results are expressed as relative cell number [%; i.e., ratio of  the cell number 





10-9 M concentration shows similar trend to the control  
 but with a reduced cell number. 
10-6 M shows an increased cell number at 6h and a drop in cell number at 




How cell cycle affects MCF-7 cells treated with B[a]P 
v MCF-7 cells were cultured in complete DMEM medium 
v 107 cells seeded in T25 flask 
v Grown for 24h (S phase) or 96h (G1/G0 phase) 
v Treated with 25μl of  B[a]P/DMSO for 24h 
v Fixed onto Low-E reflective glass slides in 70% ethanol 
v ATR-FTIR Spectroscopy used to take wavenumber measurements       
v   (Attenuated Total Reflectance Fourier Transform Infrared) 
v Data was normalised and multivariate analysis was performed 
v PCA-LDA scatter plots are shown below 
v   (Principal Component Analysis and Linear Discriminant Analysis) 




















Distinguishing regions of IR spectra from cluster vector plots 
 
 
v Spectral regions that separate treated cells from the vehicle control 
v Finding the wavenumbers of  bio molecular entities most altered        
     by identifying the 5 largest coefficient peaks 
  






 Hamouchene, H. (2011). Influence of  cell cycle on responses of  MCF-7 cells to benzo[a]pyrene. BMC Genomics. 12 
 Jiao, HY. (2007). Growth kinetics in MCF-7 cells modulate benzo[a]pyrene-induced CYP1A1 up-regulation. Mutagenisis.  22 
 Pang, W. (2012). Identification of  benzo[a]pyrene-induced cell cycle-associated alterations in MCF-7 cells using infrared spectroscopy with computational analysis 
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v To produce an integrated response profile of  
the environmental effects of  Benzo[a]Pyrene 
v To show that B[a]P plays a crucial role in 
evading G0 arrest 
v To increase our understanding of  the risks 
and underlying mechanisms of  pro-mutagens 
and pro-carcinogens 
Discussion 
Thus far this study demonstrates that B[a]P is capable of  inducing alterations in exposed cell populations even at very low doses. B[a]P gradually reduces cell 
survival after 7days exposure. However when exposed for 6hà24h, when the cells are completing S phase, a high dose of  10-6 M B[a]P induces short term 
increased proliferation. After 24h the long term inhibition of  cell growth caused by B[a]P is re-established. Despite being affected by B[a]P the cells are able to 
survive. The hypothesis that the surviving cells suffer from altered gene expression, in particular cytochrome P450 genes, will be tested in future work. 
 
Spectral analysis through PCA-LDA showed nearness similarity in S phase. Statistical tests showed r2 was low and Dunnett’s test indicates that the control and 
10-9 are not significantly different. However B[a]P 10-6 vs control is. Segregation of  category clusters in PCA-LDA represents a high degree of  dissimilarity in G 
phase. All concentrations where found to be significantly different. Cluster vectors indicated high peaks associated with alterations in DNA/RNA (vas + PO2-), 
suggesting genotoxic mechanisms of  B[a]P. This was particularly prevalent in S phase cells with B[a]P 10-6. This further fuels hypothesis that B[a]P induces an 
increased proliferation in S phase to ensure cells that have undergone DNA damage can successfully complete the cell cycle.  
 
Future work includes 
² Flow Cytometry to gain evidence that the cells are in the presumed cell cycle phases 
² Western Blots and RT-PCR to identify if  B[a]P alters gene expression of  CYP1A1, CYP1B1, BCL-2 and P21 during cell cycle 
Benzo[a]Pyrene is an environmental contaminant mainly 
found in  tobacco smoke, car exhaust fumes and industrial 
wastes. While it has been found to have pro-mutagenic and 
pro-carcinogenic properties it is not toxic until it enters the 
plasma membrane and binds to the Aryl hydrocarbon 
receptor (AhR). Once bound it activates AhR causing it to 
translocate into the nucleus where it dissociates. Active AhR 
is involved in controlling the transcription and expression of  
many genes. 
  
MCF-7 cells are a breast cancer cell line established in 1970. 
They are great for research use because of  their resilience: 
they are easy to grow and hard to kill. They also incorporate 
estrogen receptors; these are thought to interact with AhR 
during gene regulation. 
 
The Cell cycle: The G1 phase is where cell growth occurs 
while the S phase controls replication and DNA synthesis. 
Cells have to pass the restriction point, between G1 and S 
phase, in order to undergo replication and later division. If  
the restriction point is not passed then cells remain in G0 














Figure 1: The Cell Cycle  (Obtained from Clinical Tools, Inc) 
 
Failure to regulate the restriction point results in the 
avoidance of  arrest by cells. This characteristic has been 
linked to the uncontrolled growth of  tumours, as the cells are 






















B[a]P Concentration (µM)  
Benzo[a]pyrene Dose Response 
Statistical Tests S Phase G Phase 
R2 0.4126 0.7755 
ANOVA P<0.0001 P<0.0001 
Dunnett's Multiple Comparison 
Test 
C vs -9   P > 0.05 C vs -9   P < 0.01 
C vs -6   P < 0.01 C vs -6   P < 0.01 
-9 vs -6   P < 0.01 -9 vs -6  P < 0.01 





1508	  C-H Phenyl Ring	





1258	 Phosphate I (PO2-)	
1088	 Phosphate I (PO2-)	










1585	 C-C Phenyl Ring	
1543	 Amide II	
1169	 Vas CO-O-C	
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Appendix B – The graphs in this section illustrate 1D, 2D, 3D scores plots and cluster vectors 
for spectral data obtained by FTIR-ATR and Raman spectroscopy. Graphs show analysis of 
endometriosis presence, disease stage, disease morphology and ovarian endometriosis 
presence. Pre-processing methods Rubber band-Vector normalisation and SG 
differentiation – Vector normalisation are shown for the FTIR-ATR spectra. The Raman 
spectra were pre-processed using Rubber band-Vector normalisation and Rubber band-
Amide I. 
PCA-LDA results for endometriosis presence obtained from FTIR-ATR spectroscopy 
spectra that underwent Rubber band-Vector normalisation pre-processing: 
 
PCA-LDA results for endometriosis presence obtained from FTIR-ATR spectroscopy 
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PCA-LDA results for disease stage obtained from FTIR-ATR spectroscopy spectra that 
underwent Rubber band-Vector normalisation pre-processing: 
 
PCA-LDA results for disease stage obtained from FTIR-ATR spectroscopy spectra that 
underwent SG differentiation-Vector normalisation pre-processing: 
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PCA-LDA results for disease morphology obtained from FTIR-ATR spectroscopy spectra 
that underwent Rubber band-Vector normalisation pre-processing: 
 
PCA-LDA results for disease morphology obtained from FTIR-ATR spectroscopy spectra 
that underwent SG differentiation-Vector normalisation pre-processing: 
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PCA-LDA results for ovarian endometriosis presence obtained from FTIR-ATR 
spectroscopy spectra that underwent Rubber band-Vector normalisation pre-
processing: 
 
PCA-LDA results for ovarian endometriosis presence obtained from FTIR-ATR 
spectroscopy spectra that underwent SG differentiation-Vector normalisation pre-
processing: 
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PCA-LDA results for endometriosis presence obtained from Raman spectroscopy 
spectra that underwent Rubber band-Vector normalisation pre-processing: 
 
PCA-LDA results for endometriosis presence obtained from Raman spectroscopy 
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PCA-LDA results for disease stage obtained from Raman spectroscopy spectra that 
underwent Rubber band-Vector normalisation pre-processing: 
 
PCA-LDA results for disease stage obtained from Raman spectroscopy spectra that 
underwent Rubber band-Amide I pre-processing: 
 
 
In Vitro and in Vivo Biospectroscopy Applications 
 
137 | P a g e  
 
PCA-LDA results for disease morphology obtained from Raman spectroscopy spectra 
that underwent Rubber band-Vector normalisation pre-processing: 
 
PCA-LDA results for disease morphology obtained from Raman spectroscopy spectra 
that underwent Rubber band-Amide I pre-processing: 
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PCA-LDA results for ovarian endometriosis presence obtained from Raman 
spectroscopy spectra that underwent Rubber band-Vector normalisation pre-
processing: 
 
PCA-LDA results ovarian endometriosis presence obtained from Raman spectroscopy 
spectra that underwent Rubber band-Amide I pre-processing: 
 
In Vitro and in Vivo Biospectroscopy Applications 
 
139 | P a g e  
 
Appendix C – The figures in this section show raw data from the western blots. Low 
molecular weight ladder is shown in the first well on the left. The darkest band on the ladder 
is 25kDa whilst the top band indicates 75kDA.  
Raw data for western blot of BLC-2 protein expression. Band should be seen at 26kDA: 
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Raw data for western blot of CYP1B1 protein expression. Band should be seen at 61 kDA: 
 
Raw data for western blot of P21 protein expression. Band should be seen at 54kDA: 
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Appendix D – Tables illustrating the peak wavenumbers and the associated chemical 
identities for S phase and G phase treated MCF-7 cells. Peak wavenumbers were generated 
from PCA-LDA cluster vector loading plots from spectral data obtained from FTIR-ATR or 
Raman spectroscopy. 
FTIR-ATR results for MCF-7 cells treated in S phase with a B[a]P 10-9M and pre-processing using 
Rubber band-Amide I: 
Wave number [cm-1] Association 
1736 C==O stretching (lipids) 
1659 Amide I 
1589 Ring C-C stretch of phenyl 
1482 Not specified 
1474 CH2 bending of the methylene chains in lipids 
1327 Stretching C-N thymine, adenine 
1107 ν(CO), ν(CC), ring (polysaccharides, pectin) 
1022 Glycogen 
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FTIR-ATR results for MCF-7 cells treated in S phase with a B[a]P 10-6M and pre-processing using 
Rubber band-Amide I: 
Wave number [cm-1] Association 
1717 
C==O thymine 
Amide I (arises from C==O stretching vibration) 
C==O stretching vibration of DNA and RNA 
C==O stretching vibration of purine base 
1539 Not specified 
1497 C==C, deformation C-H 
1450 
Methylene deformation in biomolecules 
Polyethylene methylene deformation modes 
1292 N-H thymine 
1204 
Vibrational modes of collagen proteins-amide III 
C-O-C, C-O dominated by the ring vibrations of 
polysaccharides C-O-P, P-O-P 
Collagen 
1103 Symmetric stretching P-O-C 
964 
C-C and C-O in deoxyribose of DNA of tumor cells 
C-O deoxyribose, C-C 
C-C, C-O deoxyribose 
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FTIR-ATR results for MCF-7 cells treated in S phase with a B[a]P 10-9M and pre-processing using 
Rubber band-Vector normalisation: 
Wave number [cm-1] Association 
1720 C==O 
1659 Amide I 
1558 Ring base 
1452 Not specified 
1327 Stretching C-N thymine, adenine 
1207 
PO2- asymmetric (phosphate I) 
Collagen 
1111 ν(CO), ν(CC), ring (polysaccharides, cellulose) 
1018 ν(CO), ν(CC), δ(OCH), ring (polysaccharides, pectin) 
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FTIR-ATR results for MCF-7 cells treated in S phase with a B[a]P 10-6M and pre-processing using 
Rubber band-Vector normalisation: 
Wave number [cm-1] Association 
1720 C==O 
1842 Not specified 
1450 
Methylene deformation in biomolecules 
Polyethylene methylene deformation modes 
1288 N-H thymine 
1204 
Vibrational modes of collagen proteins-amide III 
C-O-C, C-O dominated by the ring vibrations of 
polysaccharides C-O-P, P-O-P 
Collagen 
1103 Symmetric stretching P-O-C 
999 
Ring stretching vibrations mixed strongly with CH 
in-plane bending 
C-O ribose, C-C 
961 C-O deoxyribose, C-C 
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FTIR-ATR results for MCF-7 cells treated in S phase with a B[a]P 10-9M and pre-processing using 
SG differentiation-Vector normalisation: 
Wave number [cm-1] Association 
1736 C==O stretching (lipids) 
1674 
Amide I (anti-parallel β-sheet) 
ν(C==C) trans, lipids, fatty acids 
Stretching C==O vibrations that are H-bonded 
(changes in the C==O stretching vibrations could be 
connected with destruction of old H-bonds and 
creation of the new ones) 
1547 
Protein band 
Amide II (δN-H, νC-N) 
Peptide amide II 
Amide II 
Amide II of proteins 
1508 
In-plane CH bending vibration from the phenyl rings 
CH in-plane bend 
1470 CH2 bending of the methylene chains in lipids 
1420 




Ring stretching vibrations mixed strongly with CH 
in-plane bending 
C-O ribose, C-C 
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FTIR-ATR results for MCF-7 cells treated in S phase with a B[a]P 10-6M and pre-processing using 
SG differentiation-Vector normalisation: 
Wave number [cm-1] Association 
1732 
Absorption band of fatty acid ester 
Fatty acid ester band 
1543 Amide II 
1485 
C8-H coupled with a ring vibration of guanine 
Deformation C-H 
1273 CHα' rocking 
1165 
Mainly from the C-O stretching mode of C-OH 
groups of serine, threosine, & tyrosine of proteins) 
ν(CC), δ(COH), ν(CO) stretching 
C-O stretching (in normal tissue) 
Hydrogen-bonded stretching mode of C-OH groups 
C-O stretching band of collagen (type I) 
1119 
Symmetric stretching P-O-C 




Symmetric phosphate [PO2- (sym)] stretching 
Collagen & phosphodiester groups of nucleic acids 
1003 Not specified 
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FTIR-ATR results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-9M and pre-processing 
using Rubber band-Amide I: 
Wave number [cm-1] Association 
1701 Not specified 
1651 
Amide I absorption (predominantly the C==O 
stretching vibration of the amide C==O) 
Protein amide I absorption 
C==O, stretching C==C uracyl, NH2 guanine 
Peptide amide I 
Amide I 
1558 Ring base 
1520 Amide II 
1196 Collagen 
1157 
C-O stretching vibration 
ν (C-C)-diagnostic for the presence of a carotenoid 
structure, most likely a cellular pigment 
νC-O of proteins and carbohydrates 
1022 Glycogen 
961 C-O deoxyribose, C-C 
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FTIR-ATR results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-6M and pre-processing 
using Rubber band-Amide I: 
Wave number [cm-1] Association 
1740 
C==O 
C==O stretching (lipids) 
Ester C==O stretching vibration (phospholipids) 
1701 Not specified 
1651 
Amide I absorption (predominantly the C==O 
stretching vibration of the amide C==O) 
Protein amide I absorption 
C==O, stretching C==C uracyl, NH2 guanine 
Peptide amide I 
Amide I 
1585 Ring C-C stretch of phenyl 
1543 Amide II 
1396 
Symmetric CH3 bending of the methyl groups of 
proteins 
1350 Stretching C-O, deformation C-H, deformation N-H 
1169 νas CO-O-C 
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FTIR-ATR results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-9M and pre-processing 
using Rubber band-Vector normalisation: 
Wave number [cm-1] Association 
1747 
Ester group (C==O) vibration of triglycerides 
ν(C==O) (polysaccharides, pectin) 
1701 Not specified 
1632 Ring C-C stretch of phenyl 
1604 C==C uracyl, C==O 
1585 Ring C-C stretch of phenyl 
1539 
Protein amide II absorption- predominately β-sheet 
of amide II 
1345 Not specified 
1153 
Stretching vibrations of hydrogen-bonding C-OH 
groups 
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FTIR-ATR results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-6M and pre-processing 
using Rubber band-Vector normalisation: 
Wave number [cm-1] Association 
1740 
C==O 
C==O stretching (lipids) 
Ester C==O stretching vibration (phospholipids) 
1701 Not specified 
1632 Ring C-C stretch of phenyl 
1604 C==C uracyl, C==O 
1585 Ring C-C stretch of phenyl 
1543 Amide II 
1345 Not specified 
1274 Not specified 
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FTIR-ATR results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-9M and pre-processing 
using SG differentiation-Vector normalisation: 
Wave number [cm-1] Association 
1717 
C==O thymine 
Amide I (arises from C==O stretching vibration) 
C==O stretching vibration of DNA and RNA 
C==O stretching vibration of purine base 
1643 
Amide I band (arises from C==O stretching 
vibrations) 
1555 Ring base 
1508 In-plane CH bending vibration from the phenyl rings 
1462 Paraffin 
1258 PO2- asymmetric (phosphate I) 
1169 
νas CO-O-C 
C-O bands from glycomaterials and proteins 
1107 ν(CO), ν(CC), ring (polysaccharides, pectin) 
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FTIR-ATR results for MCF-7 cells treated in G phase with a B[a]P 10-6M and pre-processing using 
SG differentiation-Vector normalisation: 
Wave number [cm-1] Association 
1717 
C==O thymine 
Amide I (arises from C==O stretching vibration) 
C==O stretching vibration of DNA and RNA 
C==O stretching vibration of purine base 
1643 
Amide I band (arises from C==O stretching 
vibrations) 
1558 Ring base 
1512 
In-plane CH bending vibration from the phenyl rings 
CH in-plane bend 
1512 
ν(C==C)-diagnostic for the presence of a carotenoid 
structure, most likely a cellular pigment 
1462 Paraffin 
1261 PO2- asymmetric (phosphate I) 
1069 Stretching C-O ribose 
  
In Vitro and in Vivo Biospectroscopy Applications 
 
153 | P a g e  
 
Raman results for MCF-7 cells treated in S phase with a B[a]P 10-9M and pre-processing using 
Rubber band-Amide I: 
Wave number [cm-1] Association 
1671 
Amide I 
C==C stretching vibrations 
Cholesterol & its esters 
C==C stretching vibration mode of steroid ring 
Amide I (anti-parallel β-sheet) 
ν(C==C) trans, lipids, fatty acids 
C==C stretch 




C-H vibration (proteins) 
C-H vibration (lipids) 
Lipids 
1318 
G (ring breathing modes of the DNA/RNA bases)-C-
H deformation (protein) 
Amide III (α-helix) 
1237 
Amide III & CH2 wagging vibrations from glycine 




Phosphodioxy group (PO2- in nucleic acids) 
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Phenylalanine (of collagen) 
νs(C-C), symmetric ring breathing, phenylalanine 
(protein assignment) 
Phenylalanine (collagen assignment) 
Phenyl breathing mode 
ν(C-C) phenylalanine 
960 
Symmetric stretching vibration of ν1PO43- 
(phosphate of HA) 
Calcium-phosphate stretch band (high quantities of 
cholesterol) 
Quinoid ring in-plane deformation 
853 
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Raman results for MCF-7 cells treated in S phase with a B[a]P 10-6M and pre-processing using 
Rubber band-Amide I: 
Wave number [cm-1] Association 
1668 
Protein band 
C==C stretching band 
α-helical structure of amide I 
Structural protein modes of tumors 
Carbonyl stretch (C==O) 
Carbonyl stretch (C==O) 
Cholesterol ester 
1591 Carbon particles 
1537 
Amide carbonyl group vibrations and aromatic 
hydrogens 
1446 
CH2 bending mode of proteins & lipids 
CH2 deformation 
1341 
Nucleic acid mode 
Differences in collagen content 
Nucleic acid modes indicating the nucleic acid 
content in tissues 
G (DNA/RNA) 





Asymmetric phosphate [PO2- (asym.)] stretching 
modes (phosphate stretching modes originate from 
the phosphodiester groups of nucleic acids and 
suggest an increase in the nucleic acids in the 
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Wave number [cm-1] Association 
 
1241 
malignant tissues). (Generally, the PO2- groups of 




Carbohydrates peak for solids 
1070 
Triglycerides (fatty acids) 
Symmetric PO2- stretching of DNA (represents 
more DNA in cell) 
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Raman results for MCF-7 cells treated in S phase with a B[a]P 10-9M and pre-processing using 
Rubber band-Vector normalisation: 
Wave number [cm-1] Association 
1649 
(C==C) Amide I 
Protein amide I absorption 
Amide I 
1285 
Differences in collagen content 
Cytosine 
1215 Stretching of C-N 
992 C-O ribose, C-C 
907 Formalin contamination peak on fixed tissues 
810 Phosphodiester (Z-marker) 
663 C-S stretching mode of cystine (collagen type I) 
657 
C-S stretching mode of cystine (collagen type I) 
C-C twisting mode of tyrosine 
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Raman results for MCF-7 cells treated in S phase with a B[a]P 10-6M and pre-processing using 
Rubber band-Vector normalisation: 




1427 Deoxyribose, (B,Z-marker) 
1340 
Nucleic acid mode 
Differences in collagen content 
Nucleic acid modes indicating the nucleic acid 
content in tissues 
1077 
C-C (lipid in normal tissues) 
Symmetric stretching vibration of ν3PO43- 
ν(C-C) or ν(C-O), phospholipids (lipid assignment) 
Phospholipids 
C-C or C-O stretching mode of phospholipids 
Carbohydrate peak for solids 
C-C or C-O stretch (lipid), C-C or PO2 stretch 
(nucleic acid) 
ν(CC) skeletal 
ν(CC) vitors (PO2-) nucleic acid 
859 Tyrosine, collagen 
765 Pyrimidine ring breathing mode 
663 C-S stretching mode of cystine (collagen type I) 
575 Phosphatidylinositol 
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Raman results for MCF-7 cells treated in S phase with a B[a]P 10-9M and pre-processing using 
SG differentiation-Vector normalisation: 
Wave number [cm-1] Association 
1649 
(C==C) Amide I 
Protein amide I absorption 
Amide I 
1591 Carbon particles 
1470 C==N stretching 
1002 
C-C aromatic ring stretching 
Phenylalanine 
Phenylalanine (collagen assignment) 
931 Carbohydrates peak for solutions and solids 
825 
Phosphodiester 
O-P-O stretch DNA 
723 DNA 
642 C-C twisting mode of tyrosine 
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Raman results for MCF-7 cells treated in S phase with a B[a]P 10-6M and pre-processing using 
SG differentiation-Vector normalisation: 
Wave number [cm-1] Association 
1737 
C==O ester (lipids) 
Lipids 
1684 




CH2 bending mode 
Due to changes in chemical environment of the CH2 
bending mode 
CH3, CH2 deformation (collagen assignment) 
Triglycerides (fatty acids) 
1321 Amide III (α-helix) 
992 C-O ribose, C-C 
831 Asymmetric O-P-O stretching, tyrosine 
645 C-C twisting mode of phenylalanine (proteins) 
530 
S-S disulfide stretching in proteins 
Phosphatidylserine 
ν(S-S) gauche-gauche-trans (aminoacid cysteine) 
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Raman results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-9M and pre-processing 
using Rubber band-Amide I: 
Wave number [cm-1] Association 
1588 Phenylalanine, hydroxyproline 
1534 
Amide carbonyl group vibrations and aromatic 
hydrogens 
1446 







C-C aromatic ring stretching 
Phenylalanine 
Phenylalanine (collagen assignment) 
929 
ν(C-C), stretching-probably in amino acids proline & 
valine (protein band) 
853 
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Raman results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-6M and pre-processing 
using Rubber band-Amide I: 
Wave number [cm-1] Association 
1391 CH rocking 
1269 Amide III (collagen assignment) 
1183 Cytosine, guanine, adenine 
1128 
C-N stretching (proteins) 
C-O stretching (carbohydrates) 
ν(C-C) skeletal of acyl backbone in lipid 
(transconformation) 
1070 Triglycerides (fatty acids) 
1004 
Phenylalanine (of collagen) 
νs(C-C), symmetric ring breathing, phenylalanine 
(protein assignment) 
Phenylalanine (collagen assignment) 




C-C stretching, hypro (collagen assignment) 
Monosaccharides (β-fructose), (C-O-C) skeletal 
mode 
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Raman results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-9M and pre-processing 
using Rubber band-Vector normalisation: 
Wave number [cm-1] Association 
1694 Amide I (turns and bands) 
1630 
Amide C==O stretching absorption for the β-form 
polypeptide films 
1454 
CH2 stretching/CH3 assymetric deformation 
Overlapping asymmetric CH3 bending & CH2 
scissoring (is associated with elastin, collagen, & 
phospholipids) 
Collagen & phospholipids 
1345 δ(CH), residual vibrations 




Symmetric ring breathing of phenylalanine 
943 
Skeletal modes (polysaccharides, amylose) 
Skeletal modes (polysaccharides, amylopectin) 
777 Phosphatidylinositol 
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Raman results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-6M and pre-processing 
using Rubber band-Vector normalisation: 
Wave number [cm-1] Association 
1592 C==N and C==C stretching in quinoid ring 
1532 
Amide carbonyl group vibrations and aromatic 
hydrogens 
1372 




CH2/CH3 wagging, twisting &/or bending mode of 
collagens & lipids 
CH2/CH3 wagging & twisting mode in collagen, 
nucleic acid & tryptophan 
1277 Amide III 
1190 
Nucleic acids and phosphates 
Electronic structure of nucleotides 
Amide III 
781 Cytosine/uracil ring breathing (nucleotide) 
726 C-S (protein), CH2 rocking, adenine 
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Raman results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-9M and pre-processing 
using SG differentiation-Vector normalisation: 
Wave number [cm-1] Association 
1672 
C==C stretch 




C==C in-plane bending mode of phenylalanine & 
tyrosine 
Ring C-C stretch of phenyl 
1413 νs COO- (IgG) 
1324 
CH3CH2 wagging mode present in collagen & 
purine bases of DNA 
1191 
Nucleic acids and phosphates 
Electronic structure of nucleotides 
Amide III 
1004 
Phenylalanine (of collagen) 
νs(C-C), symmetric ring breathing, phenylalanine 
Phenylalanine (collagen assignment) 
Phenyl breathing mode 
ν(C-C) phenylalanine 
919 
C-C stretch of proline ring/glucose/lactic acid 
C-C, praline ring (collagen assignment) 
838 Deformative vibrations od amine groups 
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Raman results for MCF-7 cells treated in G0/G1 phase with a B[a]P 10-6M and pre-processing 
using SG differentiation-Vector normalisation: 
Wave number [cm-1] Association 
1689 
Amide I (disordered structure; non hydrogen 
bonded) 
1446 
CH2 bending mode of proteins & lipids 
CH2 deformation 
1409 νs COO- (IgG) 
1002 
C-C aromatic ring stretching 
Phenylalanine 
Phenylalanine (collagen assignment) 
941 
Skeletal modes (polysaccharides, amylose) 
Skeletal modes (polysaccharides, amylopectin) 
854 
(C-O-C) skeletal mode of α-anomers 
(polysaccharides, pectin) 
Ring breathing tyrosine (proteins) 
726 C-S (protein), CH2 rocking, adenine 
645 C-C twisting mode of phenylalanine (proteins) 
 
 
